
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Prognostic Value of a 6-Minute Walk Test in Patients With Transthyretin Cardiac Amyloidosis - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="8E59B851926010033AB851006037E405.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="elsevierwt">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11218050/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Journal of the American College of Cardiology">
<meta name="citation_title" content="Prognostic Value of a 6-Minute Walk Test in Patients With Transthyretin Cardiac Amyloidosis">
<meta name="citation_author" content="Adam Ioannou">
<meta name="citation_author_institution" content="National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom">
<meta name="citation_author" content="Carlo Fumagalli">
<meta name="citation_author_institution" content="National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom">
<meta name="citation_author_institution" content="Tuscan Regional Amyloidosis Centre, Careggi University Hospital, Florence, Italy">
<meta name="citation_author" content="Yousuf Razvi">
<meta name="citation_author_institution" content="National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom">
<meta name="citation_author" content="Aldostefano Porcari">
<meta name="citation_author_institution" content="National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom">
<meta name="citation_author_institution" content="Center for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina, University of Trieste, Trieste, Italy">
<meta name="citation_author" content="Muhammad U Rauf">
<meta name="citation_author_institution" content="National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom">
<meta name="citation_author" content="Ana Martinez-Naharro">
<meta name="citation_author_institution" content="National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom">
<meta name="citation_author" content="Lucia Venneri">
<meta name="citation_author_institution" content="National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom">
<meta name="citation_author" content="William Moody">
<meta name="citation_author_institution" content="Department of Cardiology, Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom">
<meta name="citation_author_institution" content="Institute of Cardiovascular Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom">
<meta name="citation_author" content="Richard P Steeds">
<meta name="citation_author_institution" content="Department of Cardiology, Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom">
<meta name="citation_author_institution" content="Institute of Cardiovascular Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom">
<meta name="citation_author" content="Aviva Petrie">
<meta name="citation_author_institution" content="University College London, London, United Kingdom">
<meta name="citation_author" content="Carol Whelan">
<meta name="citation_author_institution" content="National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom">
<meta name="citation_author" content="Ashutosh Wechalekar">
<meta name="citation_author_institution" content="National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom">
<meta name="citation_author" content="Helen Lachmann">
<meta name="citation_author_institution" content="National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom">
<meta name="citation_author" content="Philip N Hawkins">
<meta name="citation_author_institution" content="National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom">
<meta name="citation_author" content="Scott D Solomon">
<meta name="citation_author_institution" content="Cardiovascular Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA">
<meta name="citation_author" content="Julian D Gillmore">
<meta name="citation_author_institution" content="National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom">
<meta name="citation_author" content="Marianna Fontana">
<meta name="citation_author_institution" content="National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom">
<meta name="citation_publication_date" content="2024 Jul 2">
<meta name="citation_volume" content="84">
<meta name="citation_issue" content="1">
<meta name="citation_firstpage" content="43">
<meta name="citation_doi" content="10.1016/j.jacc.2024.04.011">
<meta name="citation_pmid" content="38739065">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC11218050/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC11218050/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC11218050/pdf/main.pdf">
<meta name="description" content="The 6-minute walk test (6MWT) represents a comprehensive functional assessment that is commonly used in patients with heart failure; however, data are lacking in patients with transthyretin cardiac amyloidosis (ATTR-CA). This study aimed to assess ...">
<meta name="og:title" content="Prognostic Value of a 6-Minute Walk Test in Patients With Transthyretin Cardiac Amyloidosis">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="The 6-minute walk test (6MWT) represents a comprehensive functional assessment that is commonly used in patients with heart failure; however, data are lacking in patients with transthyretin cardiac amyloidosis (ATTR-CA). This study aimed to assess ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC11218050/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://pmc.ncbi.nlm.nih.gov/search/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="11218050">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1016/j.jacc.2024.04.011"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/main.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC11218050%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/11218050/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/11218050/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC11218050/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-elsevierwt.png" alt="Elsevier Sponsored Documents logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Elsevier Sponsored Documents" title="Link to Elsevier Sponsored Documents" shape="default" href="https://doi.org/10.1016/j.jacc.2024.04.011" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">J Am Coll Cardiol</button></div>. 2024 Jul 2;84(1):43–58. doi: <a href="https://doi.org/10.1016/j.jacc.2024.04.011" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1016/j.jacc.2024.04.011</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22J%20Am%20Coll%20Cardiol%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22J%20Am%20Coll%20Cardiol%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22J%20Am%20Coll%20Cardiol%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22J%20Am%20Coll%20Cardiol%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Prognostic Value of a 6-Minute Walk Test in Patients With Transthyretin Cardiac Amyloidosis</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ioannou%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Adam Ioannou</span></a><div hidden="hidden" id="id1">
<h3>
<span class="name western">Adam Ioannou</span>, <span class="degrees">MBBS, BSc</span>
</h3>
<div class="p">
<sup>a</sup>National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ioannou%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Adam Ioannou</span></a>
</div>
</div>
<sup>a,</sup><sup>∗</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fumagalli%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Carlo Fumagalli</span></a><div hidden="hidden" id="id2">
<h3>
<span class="name western">Carlo Fumagalli</span>, <span class="degrees">MD</span>
</h3>
<div class="p">
<sup>a</sup>National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom</div>
<div class="p">
<sup>b</sup>Tuscan Regional Amyloidosis Centre, Careggi University Hospital, Florence, Italy</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fumagalli%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Carlo Fumagalli</span></a>
</div>
</div>
<sup>a,</sup><sup>b,</sup><sup>∗</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Razvi%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Yousuf Razvi</span></a><div hidden="hidden" id="id3">
<h3>
<span class="name western">Yousuf Razvi</span>, <span class="degrees">MBChB</span>
</h3>
<div class="p">
<sup>a</sup>National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Razvi%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yousuf Razvi</span></a>
</div>
</div>
<sup>a</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Porcari%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Aldostefano Porcari</span></a><div hidden="hidden" id="id4">
<h3>
<span class="name western">Aldostefano Porcari</span>, <span class="degrees">MD</span>
</h3>
<div class="p">
<sup>a</sup>National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom</div>
<div class="p">
<sup>c</sup>Center for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina, University of Trieste, Trieste, Italy</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Porcari%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Aldostefano Porcari</span></a>
</div>
</div>
<sup>a,</sup><sup>c</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rauf%20MU%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Muhammad U Rauf</span></a><div hidden="hidden" id="id5">
<h3>
<span class="name western">Muhammad U Rauf</span>, <span class="degrees">MBBS</span>
</h3>
<div class="p">
<sup>a</sup>National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rauf%20MU%22%5BAuthor%5D" class="usa-link"><span class="name western">Muhammad U Rauf</span></a>
</div>
</div>
<sup>a</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Martinez-Naharro%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Ana Martinez-Naharro</span></a><div hidden="hidden" id="id6">
<h3>
<span class="name western">Ana Martinez-Naharro</span>, <span class="degrees">PhD</span>
</h3>
<div class="p">
<sup>a</sup>National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Martinez-Naharro%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Ana Martinez-Naharro</span></a>
</div>
</div>
<sup>a</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Venneri%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Lucia Venneri</span></a><div hidden="hidden" id="id7">
<h3>
<span class="name western">Lucia Venneri</span>, <span class="degrees">MD, PhD</span>
</h3>
<div class="p">
<sup>a</sup>National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Venneri%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Lucia Venneri</span></a>
</div>
</div>
<sup>a</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Moody%20W%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">William Moody</span></a><div hidden="hidden" id="id8">
<h3>
<span class="name western">William Moody</span>, <span class="degrees">MBChB, PhD</span>
</h3>
<div class="p">
<sup>d</sup>Department of Cardiology, Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom</div>
<div class="p">
<sup>e</sup>Institute of Cardiovascular Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Moody%20W%22%5BAuthor%5D" class="usa-link"><span class="name western">William Moody</span></a>
</div>
</div>
<sup>d,</sup><sup>e</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Steeds%20RP%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Richard P Steeds</span></a><div hidden="hidden" id="id9">
<h3>
<span class="name western">Richard P Steeds</span>, <span class="degrees">MD</span>
</h3>
<div class="p">
<sup>d</sup>Department of Cardiology, Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom</div>
<div class="p">
<sup>e</sup>Institute of Cardiovascular Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Steeds%20RP%22%5BAuthor%5D" class="usa-link"><span class="name western">Richard P Steeds</span></a>
</div>
</div>
<sup>d,</sup><sup>e</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Petrie%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Aviva Petrie</span></a><div hidden="hidden" id="id10">
<h3>
<span class="name western">Aviva Petrie</span>, <span class="degrees">MSc</span>
</h3>
<div class="p">
<sup>f</sup>University College London, London, United Kingdom</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Petrie%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Aviva Petrie</span></a>
</div>
</div>
<sup>f</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Whelan%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Carol Whelan</span></a><div hidden="hidden" id="id11">
<h3>
<span class="name western">Carol Whelan</span>, <span class="degrees">MD</span>
</h3>
<div class="p">
<sup>a</sup>National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Whelan%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Carol Whelan</span></a>
</div>
</div>
<sup>a</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wechalekar%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Ashutosh Wechalekar</span></a><div hidden="hidden" id="id12">
<h3>
<span class="name western">Ashutosh Wechalekar</span>, <span class="degrees">MD</span>
</h3>
<div class="p">
<sup>a</sup>National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wechalekar%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Ashutosh Wechalekar</span></a>
</div>
</div>
<sup>a</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lachmann%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">Helen Lachmann</span></a><div hidden="hidden" id="id13">
<h3>
<span class="name western">Helen Lachmann</span>, <span class="degrees">MD</span>
</h3>
<div class="p">
<sup>a</sup>National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Lachmann%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Helen Lachmann</span></a>
</div>
</div>
<sup>a</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hawkins%20PN%22%5BAuthor%5D" class="usa-link" aria-describedby="id14"><span class="name western">Philip N Hawkins</span></a><div hidden="hidden" id="id14">
<h3>
<span class="name western">Philip N Hawkins</span>, <span class="degrees">MD, PhD</span>
</h3>
<div class="p">
<sup>a</sup>National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hawkins%20PN%22%5BAuthor%5D" class="usa-link"><span class="name western">Philip N Hawkins</span></a>
</div>
</div>
<sup>a</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Solomon%20SD%22%5BAuthor%5D" class="usa-link" aria-describedby="id15"><span class="name western">Scott D Solomon</span></a><div hidden="hidden" id="id15">
<h3>
<span class="name western">Scott D Solomon</span>, <span class="degrees">MD</span>
</h3>
<div class="p">
<sup>g</sup>Cardiovascular Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Solomon%20SD%22%5BAuthor%5D" class="usa-link"><span class="name western">Scott D Solomon</span></a>
</div>
</div>
<sup>g</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gillmore%20JD%22%5BAuthor%5D" class="usa-link" aria-describedby="id16"><span class="name western">Julian D Gillmore</span></a><div hidden="hidden" id="id16">
<h3>
<span class="name western">Julian D Gillmore</span>, <span class="degrees">MD, PhD</span>
</h3>
<div class="p">
<sup>a</sup>National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gillmore%20JD%22%5BAuthor%5D" class="usa-link"><span class="name western">Julian D Gillmore</span></a>
</div>
</div>
<sup>a,</sup><sup>†</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fontana%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id17"><span class="name western">Marianna Fontana</span></a><div hidden="hidden" id="id17">
<h3>
<span class="name western">Marianna Fontana</span>, <span class="degrees">MD, PhD</span>
</h3>
<div class="p">
<sup>a</sup>National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fontana%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Marianna Fontana</span></a>
</div>
</div>
<sup>a,</sup><sup>∗,</sup><sup>†</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff1">
<sup>a</sup>National Amyloidosis Centre, University College London, Royal Free Campus, London, United Kingdom</div>
<div id="aff2">
<sup>b</sup>Tuscan Regional Amyloidosis Centre, Careggi University Hospital, Florence, Italy</div>
<div id="aff3">
<sup>c</sup>Center for Diagnosis and Treatment of Cardiomyopathies, Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano-Isontina, University of Trieste, Trieste, Italy</div>
<div id="aff4">
<sup>d</sup>Department of Cardiology, Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom</div>
<div id="aff5">
<sup>e</sup>Institute of Cardiovascular Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom</div>
<div id="aff6">
<sup>f</sup>University College London, London, United Kingdom</div>
<div id="aff7">
<sup>g</sup>Cardiovascular Division, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA</div>
<div class="author-notes p">
<div class="fn" id="cor1">
<sup>∗</sup><p class="display-inline"><strong>Address for correspondence:</strong> Dr Marianna Fontana, National Amyloidosis Centre, University College London, Royal Free Hospital, Rowland Hill Street, London NW3 2PF, United Kingdom. <span>m.fontana@ucl.ac.uk</span></p>
</div>
<div class="fn" id="fn1">
<sup>∗</sup><p class="display-inline" id="ntpara0015">Drs Ioannou and Fumagalli contributed equally to this work as first authors.</p>
</div>
<div class="fn" id="fn2">
<sup>†</sup><p class="display-inline" id="ntpara0020">Drs Gioomore and Fontana contributed equally to this work as last authors.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2024 Mar 13; Revised 2024 Apr 3; Accepted 2024 Apr 10.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2024 The Authors</div>
<p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC11218050  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/38739065/" class="usa-link">38739065</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abs0010"><h2>Abstract</h2>
<section id="sec1_pmc"><h3 class="pmc_sec_title">Background</h3>
<p>The 6-minute walk test (6MWT) represents a comprehensive functional assessment that is commonly used in patients with heart failure; however, data are lacking in patients with transthyretin cardiac amyloidosis (ATTR-CA).</p></section><section id="sec2_pmc"><h3 class="pmc_sec_title">Objectives</h3>
<p>This study aimed to assess the prognostic importance of the 6MWT in patients with ATTR-CA.</p></section><section id="sec3_pmc"><h3 class="pmc_sec_title">Methods</h3>
<p>A retrospective analysis of patients diagnosed with ATTR-CA at the National Amyloidosis Centre who underwent a baseline 6MWT between 2011 and 2023 identified 2,141 patients, of whom 1,118 had follow-up at 1 year.</p></section><section id="sec4_pmc"><h3 class="pmc_sec_title">Results</h3>
<p>The median baseline 6MWT distance was 347 m (Q1-Q3: 250-428 m) and analysis by quartiles demonstrated an increased death rate with each distance reduction (deaths per 100 person-years: 6.3 vs 9.2 vs 13.6 vs 19.0; log-rank <em>P</em> &lt; 0.001). A 6MWT distance of &lt;350 m was associated with a 2.2-fold higher risk of mortality (HR: 2.15; 95% CI: 1.85-2.50; <em>P</em> &lt; 0.001), with a similar increased risk across National Amyloidosis Centre disease stages (<em>P</em> for interaction = 0.761) and genotypes (<em>P</em> for interaction = 0.172). An absolute (reduction of &gt;35 m) and relative worsening (reduction of &gt;5%) of 6MWT at 1 year was associated with an increased risk of mortality (HR: 1.80; 95% CI: 1.51-2.15; <em>P</em> &lt; 0.001 and HR: 1.89; 95% CI: 1.59-2.24; <em>P</em> &lt; 0.001, respectively), which was similar across the aforementioned subgroups. When combined with established measures of disease progression (N-terminal pro–B-type natriuretic peptide progression and outpatient diuretic intensification), each incremental increase in progression markers was associated with an increased death rate (deaths per 100 person-years: 7.6 vs 13.9 vs 22.4 vs 32.9; log-rank <em>P</em> &lt; 0.001).</p></section><section id="sec5"><h3 class="pmc_sec_title">Conclusions</h3>
<p>The baseline 6MWT distance can refine risk stratification beyond traditional prognosticators. A worsening 6MWT distance can stratify disease progression and, when combined with established markers, identifies patients at the highest risk of mortality.</p></section><section id="kwrds0010" class="kwd-group"><p><strong>Key Words:</strong> 6-minute walk test, cardiac ATTR amyloidosis, prognosis</p></section></section><section class="abstract" id="abs0015"><h2>Central Illustration</h2>
<figure class="fig xbox font-sm" id="undfig1"><p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11218050_ga1.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0e3/11218050/5f99c59928bf/ga1.jpg" loading="lazy" height="549" width="765" alt="graphic file with name ga1.jpg"></a></p>
<div class="p text-right font-secondary"><a href="figure/undfig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></figure></section><hr class="headless">
<p id="p0010">Transthyretin cardiac amyloidosis (ATTR-CA) is a progressive and ultimately fatal cardiomyopathy, characterized by the deposition of misfolded transthyretin in the form of amyloid fibrils within the myocardial extracellular space, which disrupt cardiac structure and function.<a href="#bib1" class="usa-link" aria-describedby="bib1"><sup>1</sup></a><sup>,</sup><a href="#bib2" class="usa-link" aria-describedby="bib2"><sup>2</sup></a> The sporadic, noninherited, wild type (wtATTR-CA) is a condition of older, predominantly male individuals, whereas the hereditary form (hATTR-CA) can present earlier in life with a varying clinical phenotype, often comprising both restrictive cardiomyopathy and polyneuropathy.<a href="#bib3" class="usa-link" aria-describedby="bib3"><sup>3</sup></a><sup>,</sup><a href="#bib4" class="usa-link" aria-describedby="bib4"><sup>4</sup></a></p>
<p id="p0015">The 6-minute walk test (6MWT) is a well-established measure of functional exercise capacity and has demonstrated utility in the stratification of prognosis and assessment of treatment response in patients with heart failure in both clinical practice and clinical trials.<a href="#bib5" class="usa-link" aria-describedby="bib5"><sup>5</sup></a><sup>,</sup><a href="#bib6" class="usa-link" aria-describedby="bib6"><sup>6</sup></a></p>
<p id="p0020">This metric has been widely used in clinical trials to assess the efficacy of ATTR-specific disease modifiers.<a href="#bib7" class="usa-link" aria-describedby="bib7"><sup>7</sup></a><sup>, </sup><a href="#bib8" class="usa-link" aria-describedby="bib8"><sup>8</sup></a><sup>, </sup><a href="#bib9" class="usa-link" aria-describedby="bib9"><sup>9</sup></a> Tafamidis and acoramidis, both highly specific transthyretin (TTR) stabilizers, reduce the composite of all-cause mortality and cardiovascular-related hospitalization in patients with ATTR-CA. The ATTR-ACT (Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy) and ATTRibute-CM (Efficacy and Safety of AG10 in Subjects with Transthyretin Amyloid Cardiomyopathy) trials demonstrated that along with reduced all-cause mortality and cardiovascular-related hospitalization, treatment with tafamidis and acoramidis was associated with a slower rate of decline in 6MWT distance.<a href="#bib7" class="usa-link" aria-describedby="bib7"><sup>7</sup></a><sup>,</sup><a href="#bib8" class="usa-link" aria-describedby="bib8"><sup>8</sup></a> More recently, the efficacy of the RNA interference agent patisiran was assessed in the APOLLO-B (A Study to Evaluate Patisiran in Participants With Transthyretin Amyloidosis With Cardiomyopathy) trial, where the primary endpoint was the change in 6MWT at 1 year, and treatment with patisiran was shown to slow the rate of decline in 6MWT distance.<a href="#bib9" class="usa-link" aria-describedby="bib9"><sup>9</sup></a></p>
<p id="p0025">The only drug currently approved for the treatment of ATTR-CA is tafamidis.<a href="#bib7" class="usa-link" aria-describedby="bib7"><sup>7</sup></a> However, several novel compounds that inhibit TTR synthesis and subsequent amyloid formation are in advanced stages of development and are likely to become available soon in clinical practice.<a href="#bib10" class="usa-link" aria-describedby="bib10"><sup>10</sup></a> Worsening in functional capacity is one of the key elements in the assessment of disease progression and might highlight the need to switch to alternative agents with different mechanisms of action or consider combination therapy. Objective assessment of functional capacity with the 6MWT will therefore be crucial in guiding treatment decisions.</p>
<p id="p0030">Despite widespread use of the 6MWT in clinical trials and the potential key role of the 6MWT in clinical practice, the prognostic importance of the 6MWT distance in patients with ATTR-CA as well as the significance of changes in 6MWT distance over time are yet to be characterized.</p>
<p id="p0035">The aims of this study were to assess the prognostic importance of the baseline 6MWT distance and assess the prognostic importance of a change in 6MWT distance as a marker of disease progression in a large cohort of patients with ATTR-CA.</p>
<section id="sec1"><h2 class="pmc_sec_title">Methods</h2>
<p id="p0040">This is a retrospective observational cohort study of patients diagnosed with ATTR-CA at the National Amyloidosis Centre (NAC) between 2011 and 2023. The diagnosis of ATTR-CA was established on the basis of validated diagnostic criteria,<a href="#bib11" class="usa-link" aria-describedby="bib11"><sup>11</sup></a> and patients who underwent a baseline 6MWT in accordance with the American Thoracic Society guidelines were eligible for inclusion.<a href="#bib12" class="usa-link" aria-describedby="bib12"><sup>12</sup></a> All patients underwent genetic sequencing of the <em>TTR</em> gene and provided written consent for their data to be retrospectively analyzed and published, in line with the Declaration of Helsinki and approval from the Royal Free Hospital ethics committee (REC 21/PR/0620).</p>
<section id="sec1.1"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p id="p0045">Statistical analysis was performed using Stata, release 17 (StataCorp). All continuous variables were tested for normality (Shapiro-Wilk test) and are presented as mean ± SD if the distribution is normal or median (Q1-Q3) otherwise, other than N-terminal pro–B-type natriuretic peptide (NT-proBNP), which was log-transformed for bivariate testing. The independent-samples Student’s <em>t-</em>test was used to compare means if the data were normally distributed in each group, or its nonparametric equivalent was used to compare the distributions of the 2 groups. One-way analysis of variance if the data were normally distributed in each group was used to compare means in more than 2 groups, or its nonparametric equivalent was used to compare the distributions of multiple groups. A significant result was followed by post hoc Bonferroni corrected pairwise comparisons to establish where differences lay. Categorical data are presented as absolute number and frequency (%) and compared using the chi-square test.</p>
<p id="p0050">The relationships between the change in 6MWT, baseline characteristics, and other established markers of disease progression were assessed using linear regression, with the outcome variable being the 1-year 6MWT distance and explanatory variables being the baseline 6MWT distance and either NT-proBNP progression (defined as an increase of &gt;700 ng/L and &gt;30%) or outpatient diuretic intensification (ODI) (defined as any initiation or increment in the dosage of loop diuretic [furosemide equivalent]).<a href="#bib13" class="usa-link" aria-describedby="bib13"><sup>13</sup></a> To assess whether the decline in 6MWT changed according to the time period, the population was divided into a historical cohort (pre-2017) and a contemporary cohort (post-2017). The relationship was estimated by preforming a linear regression analysis, with the outcome variable being the 1-year 6MWT distance and the explanatory variables being the baseline 6MWT distance and the group being evaluated. The estimated regression coefficient represented the estimated difference in means at 1 year after adjustment for the baseline value. All variables with a <em>P</em> value of &lt;0.10 in the univariable analysis were included in the multivariable analysis.</p>
<p id="p0055">The optimal cutpoints for the baseline 6MWT distance and change in 6MWT distance at 1 year were established using time-dependent receiver operating characteristic curves, followed by the Youden method. The optimal cutpoint for the baseline 6MWT distance was 336 m (sensitivity: 56.5%, specificity: 64.0%), and a cutpoint of 350 m (sensitivity: 61.1%, specificity: 58.5%) was a good discriminator of survival by the log-rank test. The optimal cutpoint for the absolute change in 6MWT distance at 1 year was –35 m (sensitivity: 47.1%, specificity: 71.3%), and this was a good discriminator of survival by the log-rank test. The optimal cutpoint for a relative change in 6MWT distance was –5.5% (sensitivity: 57.6%, specificity: 62.2%), and cutpoint of a reduction of –5% (sensitivity: 58.3%, specificity: 61.3%) was a good discriminator of survival by the log-rank test. An absolute worsening of the 6MWT distance was defined as a reduction of &gt;35 m, and a relative worsening was defined as a reduction of &gt;5%, which exceeded the previously reported minimal clinically important difference in patients with chronic heart failure.<a href="#bib14" class="usa-link" aria-describedby="bib14"><sup>14</sup></a><sup>, </sup><a href="#bib15" class="usa-link" aria-describedby="bib15"><sup>15</sup></a><sup>, </sup><a href="#bib16" class="usa-link" aria-describedby="bib16"><sup>16</sup></a></p>
<p id="p0060">Survival was evaluated using Cox proportional hazards regression analysis, providing estimated HRs with 95% CIs. The proportional hazards assumption was checked and confirmed using weighted Schoenfeld residuals. The initial survival analysis evaluated the association between baseline 6MWT distance and all-cause mortality. Significant results were followed by internal validation of the model, which was achieved by performing a bootstrapping procedure with 500 repeats, affording a comparison of the percentile and bias-corrected methods to ensure the results were unbiased, followed by a sensitivity analysis whereby patients were censored at the start date of disease-modifying therapy and clinical trials to account for their impact on survival. To assess the potential modification of effects across different baseline characteristics, additional models were created with an interaction term, and the equality of coefficients associated with the interaction term was explicitly tested. Multivariable Cox regression models were adjusted for known predictors of mortality, and collinearity was assessed using variance inflation factors with the threshold equal to 5.</p>
<p id="p0065">The likelihood ratio test was used to evaluate the contribution of adding the 6MWT distance to the NAC disease stage model. The Akaike information criterion and Harrell C-statistic were calculated to measure the discriminatory ability of each model. The C-statistics were compared by randomly dividing the dataset into 2 cohorts (1:1). The models were fitted to the first cohort, and the C-statistics were compared in the second cohort using Student’s <em>t</em>-test after creating jackknife standard errors.</p>
<p id="p0070">Landmark survival analysis was carried out to assess the relationship between worsening of the 6MWT distance at the 1-year follow-up timepoint and all-cause mortality from the 1-year timepoint onward. Kaplan-Meier curves were constructed to view survival in different groups. Statistical significance was defined as <em>P</em> &lt; 0.05.</p></section></section><section id="sec2"><h2 class="pmc_sec_title">Results</h2>
<section id="sec2.1"><h3 class="pmc_sec_title">Baseline characteristics</h3>
<p id="p0075">The study population comprised 2,141 patients diagnosed with ATTR-CA, of whom 1,573 (73.5%) had wtATTR-CA, 292 (13.6%) had p.(V142I) hATTR-CA, and 276 (12.9%) had non-p.(V142I) hATTR-CA. The mean age of the population was 76.5 ± 8.4 years, and 1,885 (88.0%) were male. The median NT-proBNP level was 2,581 ng/L (Q1-Q3: 1,315-4,583 ng/L), the median estimated glomerular filtration rate (eGFR) was 60 mL/min/1.73 m<sup>2</sup> (Q1-Q3: 47-73 mL/min/1.73 m<sup>2</sup>), and most of the population had NAC stage 1 (51.1%) or NAC stage 2 (34.2%) disease (<a href="#tbl1" class="usa-link">Table 1</a>). During follow-up, 259 patients were enrolled into clinical trials, and 212 were initiated on disease-modifying therapy (patisiran: n = 100; tafamidis: n = 97; inotersen: n = 10; vutrisiran: n = 5).</p>
<section class="tw xbox font-sm" id="tbl1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Baseline Characteristics for Patients Diagnosed With ATTR-CA (N = 2,141)</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups"><tbody>
<tr>
<td colspan="1" rowspan="1">Baseline characteristics</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Age, y</td>
<td align="center" colspan="1" rowspan="1">76.5 ± 8.4</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Male</td>
<td align="center" colspan="1" rowspan="1">1,885 (88.0)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Ethnicity</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> White</td>
<td align="center" colspan="1" rowspan="1">1,759 (82.2)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Afro-Caribbean</td>
<td align="center" colspan="1" rowspan="1">353 (16.5)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Asian</td>
<td align="center" colspan="1" rowspan="1">21 (1.0)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Other</td>
<td align="center" colspan="1" rowspan="1">8 (0.4)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Genotypes</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> wtATTR</td>
<td align="center" colspan="1" rowspan="1">1,573 (73.5)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> p.(V142I) hATTR</td>
<td align="center" colspan="1" rowspan="1">292 (13.6)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Non-p.(V142I) hATTR</td>
<td align="center" colspan="1" rowspan="1">276 (12.9)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Heart failure severity</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> NYHA functional class</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> I</td>
<td align="center" colspan="1" rowspan="1">282 (13.2)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> II</td>
<td align="center" colspan="1" rowspan="1">1,368 (63.9)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> III</td>
<td align="center" colspan="1" rowspan="1">333 (15.6)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> IV</td>
<td align="center" colspan="1" rowspan="1">13 (0.6)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Missing</td>
<td align="center" colspan="1" rowspan="1">145</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> 6MWT distance, m</td>
<td align="center" colspan="1" rowspan="1">347 (250-427)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> 6MWT, % predicted</td>
<td align="center" colspan="1" rowspan="1">71.2 ± 26.8</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Systolic blood pressure, mm Hg</td>
<td align="center" colspan="1" rowspan="1">125.8 ± 17.3</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Diastolic blood pressure, mm Hg</td>
<td align="center" colspan="1" rowspan="1">75.0 ± 10.2</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Heart rate, beats/min</td>
<td align="center" colspan="1" rowspan="1">72.0 ± 12.8</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Blood biomarkers</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> NAC stage</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> 1</td>
<td align="center" colspan="1" rowspan="1">1,095 (51.1)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> 2</td>
<td align="center" colspan="1" rowspan="1">732 (34.2)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> 3</td>
<td align="center" colspan="1" rowspan="1">314 (14.7)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> NT-proBNP, ng/L</td>
<td align="center" colspan="1" rowspan="1">2,581 (1,315-4,581)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> eGFR, mL/min/1.73 m<sup>2</sup>
</td>
<td align="center" colspan="1" rowspan="1">60 (47-73)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Hemoglobin, g/L</td>
<td align="center" colspan="1" rowspan="1">138 (127-148)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Serum total bilirubin, μmol/L</td>
<td align="center" colspan="1" rowspan="1">13 (9-18)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Alanine transaminase, IU/L</td>
<td align="center" colspan="1" rowspan="1">25 (19-33)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Alkaline phosphatase, IU/L</td>
<td align="center" colspan="1" rowspan="1">90 (71-119)</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> GGT, IU/L</td>
<td align="center" colspan="1" rowspan="1">67 (32-134)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Echocardiographic parameters</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> IVSd, mm</td>
<td align="center" colspan="1" rowspan="1">16.8 ± 2.5</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> PWTd, mm</td>
<td align="center" colspan="1" rowspan="1">16.3 ± 3.6</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> LVEF, %</td>
<td align="center" colspan="1" rowspan="1">49.0 ± 10.7</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Longitudinal strain, %</td>
<td align="center" colspan="1" rowspan="1">–11.2 ± 3.9</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> E/e′</td>
<td align="center" colspan="1" rowspan="1">16.5 ± 7.2</td>
</tr>
</tbody></table></div>
<div class="p text-right font-secondary"><a href="table/tbl1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="tspara0015"><p>Values are mean ± SD, n (%), n, or median (Q1-Q3).</p></div>
<div class="fn" id="tspara0020"><p>ATTR-CA = transthyretin cardiac amyloidosis; eGFR = estimated glomerular filtration rate; GGT = gamma-glutamyl transferase; hATTR-CA = hereditary transthyretin cardiac amyloidosis; IVSd = interventricular septum in diastole; LVEF = left ventricular ejection fraction; NAC = National Amyloidosis Centre; NT-proBNP = N-terminal pro–B-type natriuretic peptide; PWTd = posterior wall thickness in diastole; wtATTR-CA = wild-type transthyretin cardiac amyloidosis.</p></div>
</div></section><p id="p0080">The median 6MWT distance was 347 m (Q1-Q3: 250-428 m), and the mean percent predicted distance corrected for age and height was 71.2% ± 27.8%. Analysis by 6MWT distance quartiles demonstrated that patients with a shorter 6MWT distance tended to be older, were more often female, were more often Afro-Caribbean, and more commonly had the p.(V142I) genotype. Patients with non-p.(V142I) hATTR-CA walked the farthest at their baseline assessment, followed by those with wtATTR-CA and p.(V142I) hATTR-CA (393 m [Q1-Q3: 293-468 m] vs 351 m [Q1-Q3: 255-426 m] vs 276 m [Q1-Q3: 184-388 m]; <em>P</em> &lt; 0.001); however, after correction for age and height, patients with wtATTR-CA had the greatest percent predicted distance, followed by non-p.(V142I) hATTR-CA and p.(V142I) hATTR-CA (72.9% ± 26.3% vs 70.6% ± 26.3% vs 62.6% ± 27.9%; <em>P</em> &lt; 0.001).</p>
<p id="p0085">The severity of the cardiac phenotype also worsened with each reduction in 6MWT distance quartile, as evidenced by a greater proportion of patients being in NYHA functional class III/IV and a greater proportion having NAC stage 3 (severe) disease, driven by a significantly higher median NT-proBNP level and lower eGFR. Patients with a shorter 6MWT also had higher biomarkers suggestive of hepatic congestion (elevated alkaline phosphatase and gamma-glutamyl transferase levels). Assessment of echocardiographic parameters demonstrated patients with a shorter 6MWT had worse systolic and diastolic left ventricular function but similar increase in wall thickness (<a href="#tbl2" class="usa-link">Table 2</a>). Similar trends were also observed when patients were divided into quartiles based on their percent predicted 6MWT distance (<a href="#tbl3" class="usa-link">Table 3</a>).</p>
<section class="tw xbox font-sm" id="tbl2"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>Baseline Characteristics for Patients Diagnosed With ATTR-CA Divided by the 6MWT Distance Quartile</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr>
<th rowspan="2" colspan="1"></th>
<th colspan="4" rowspan="1">6MWT Distance Quartiles<hr>
</th>
<th rowspan="2" colspan="1">
<em>P</em> Value</th>
</tr>
<tr>
<th colspan="1" rowspan="1">&gt;427 m (n = 535)</th>
<th colspan="1" rowspan="1">348-427 m (n = 535)</th>
<th colspan="1" rowspan="1">250-347 m (n = 536)</th>
<th colspan="1" rowspan="1">&lt;250 m (n = 535)</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="1" rowspan="1">Baseline characteristics</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Age, y</td>
<td align="center" colspan="1" rowspan="1">71.8 ± 9.2<a href="#tbl2fna" class="usa-link"><sup>a</sup></a><sup>,</sup><a href="#tbl2fnb" class="usa-link"><sup>b</sup></a><sup>,</sup><a href="#tbl2fnc" class="usa-link"><sup>c</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">76.0 ± 8.0<a href="#tbl2fnd" class="usa-link"><sup>d</sup></a><sup>,</sup><a href="#tbl2fne" class="usa-link"><sup>e</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">78.4 ± 7.0<a href="#tbl2fnf" class="usa-link"><sup>f</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">79.6 ± 7.1</td>
<td align="center" colspan="1" rowspan="1">&lt;0.001</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Male</td>
<td align="center" colspan="1" rowspan="1">503 (94.0)<a href="#tbl2fnc" class="usa-link"><sup>c</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">481 (89.9)<a href="#tbl2fne" class="usa-link"><sup>e</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">481 (89.7)<a href="#tbl2fnf" class="usa-link"><sup>f</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">420 (78.5)</td>
<td align="center" colspan="1" rowspan="1">&lt;0.001</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Ethnicity</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">&lt;0.001</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> White</td>
<td align="center" colspan="1" rowspan="1">480 (89.7)</td>
<td align="center" colspan="1" rowspan="1">459 (85.8)<a href="#tbl2fne" class="usa-link"><sup>e</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">431 (80.4)<a href="#tbl2fnf" class="usa-link"><sup>f</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">389 (72.7)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Afro-Caribbean</td>
<td align="center" colspan="1" rowspan="1">50 (9.3)</td>
<td align="center" colspan="1" rowspan="1">66 (12.3)<a href="#tbl2fne" class="usa-link"><sup>e</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">97 (18.1)<a href="#tbl2fnf" class="usa-link"><sup>f</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">140 (26.2)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Asian</td>
<td align="center" colspan="1" rowspan="1">3 (0.6)</td>
<td align="center" colspan="1" rowspan="1">7 (1.3)</td>
<td align="center" colspan="1" rowspan="1">6 (1.1)</td>
<td align="center" colspan="1" rowspan="1">5 (0.9)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Other</td>
<td align="center" colspan="1" rowspan="1">2 (0.4)</td>
<td align="center" colspan="1" rowspan="1">3 (0.6)</td>
<td align="center" colspan="1" rowspan="1">2 (0.4)</td>
<td align="center" colspan="1" rowspan="1">1 (0.2)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Genotypes</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">&lt;0.001</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> wtATTR</td>
<td align="center" colspan="1" rowspan="1">389 (72.7)</td>
<td align="center" colspan="1" rowspan="1">412 (77.0)<a href="#tbl2fne" class="usa-link"><sup>e</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">408 (76.1)<a href="#tbl2fnf" class="usa-link"><sup>f</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">364 (68.0)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> p.(V142I) hATTR</td>
<td align="center" colspan="1" rowspan="1">43 (8.0)<a href="#tbl2fna" class="usa-link"><sup>a</sup></a><sup>,</sup><a href="#tbl2fnb" class="usa-link"><sup>b</sup></a><sup>,</sup><a href="#tbl2fnc" class="usa-link"><sup>c</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">52 (9.7)</td>
<td align="center" colspan="1" rowspan="1">78 (14.6)</td>
<td align="center" colspan="1" rowspan="1">119 (22.2)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Non-p.(V142I) hATTR</td>
<td align="center" colspan="1" rowspan="1">103 (19.3)<a href="#tbl2fna" class="usa-link"><sup>a</sup></a><sup>,</sup><a href="#tbl2fnb" class="usa-link"><sup>b</sup></a><sup>,</sup><a href="#tbl2fnc" class="usa-link"><sup>c</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">71 (13.3)</td>
<td align="center" colspan="1" rowspan="1">50 (9.3)</td>
<td align="center" colspan="1" rowspan="1">52 (9.7)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1">Heart failure severity</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> NYHA functional class</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">&lt;0.001</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> I</td>
<td align="center" colspan="1" rowspan="1">135 (25.2)<a href="#tbl2fna" class="usa-link"><sup>a</sup></a><sup>,</sup><a href="#tbl2fnb" class="usa-link"><sup>b</sup></a><sup>,</sup><a href="#tbl2fnc" class="usa-link"><sup>c</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">60 (11.2)<a href="#tbl2fne" class="usa-link"><sup>e</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">57 (10.6)<a href="#tbl2fnf" class="usa-link"><sup>f</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">30 (5.6)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> II</td>
<td align="center" colspan="1" rowspan="1">355 (62.6)<a href="#tbl2fnc" class="usa-link"><sup>c</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">371 (69.3)<a href="#tbl2fne" class="usa-link"><sup>e</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">356 (66.4)<a href="#tbl2fnf" class="usa-link"><sup>f</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">286 (53.5)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> III</td>
<td align="center" colspan="1" rowspan="1">23 (4.3)<a href="#tbl2fnc" class="usa-link"><sup>c</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">61 (11.4)<a href="#tbl2fne" class="usa-link"><sup>e</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">75 (14.0)<a href="#tbl2fnf" class="usa-link"><sup>f</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">174 (32.5)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> IV</td>
<td align="center" colspan="1" rowspan="1">0 (0.0)<a href="#tbl2fnc" class="usa-link"><sup>c</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">1 (0.2)<a href="#tbl2fne" class="usa-link"><sup>e</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">2 (0.4)</td>
<td align="center" colspan="1" rowspan="1">10 (1.9)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Missing</td>
<td align="center" colspan="1" rowspan="1">22</td>
<td align="center" colspan="1" rowspan="1">42</td>
<td align="center" colspan="1" rowspan="1">46</td>
<td align="center" colspan="1" rowspan="1">35</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> 6MWT, % predicted</td>
<td align="center" colspan="1" rowspan="1">97.7 ± 15.5<a href="#tbl2fna" class="usa-link"><sup>a</sup></a><sup>,</sup><a href="#tbl2fnb" class="usa-link"><sup>b</sup></a><sup>,</sup><a href="#tbl2fnc" class="usa-link"><sup>c</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">83.5 ± 11.7<a href="#tbl2fnd" class="usa-link"><sup>d</sup></a><sup>,</sup><a href="#tbl2fne" class="usa-link"><sup>e</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">78.4 ± 7.0<a href="#tbl2fnf" class="usa-link"><sup>f</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">35.6 ± 15.5</td>
<td align="center" colspan="1" rowspan="1">&lt;0.001</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Systolic blood pressure, mm Hg</td>
<td align="center" colspan="1" rowspan="1">126.7 ± 16.2</td>
<td align="center" colspan="1" rowspan="1">126.9 ± 17.8</td>
<td align="center" colspan="1" rowspan="1">125.0 ± 17.5</td>
<td align="center" colspan="1" rowspan="1">124.7 ± 17.7</td>
<td align="center" colspan="1" rowspan="1">0.048</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Diastolic blood pressure, mm Hg</td>
<td align="center" colspan="1" rowspan="1">77.0 ± 9.8<a href="#tbl2fnb" class="usa-link"><sup>b</sup></a><sup>,</sup><a href="#tbl2fnc" class="usa-link"><sup>c</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">75.3 ± 10.4</td>
<td align="center" colspan="1" rowspan="1">74.2 ± 10.1</td>
<td align="center" colspan="1" rowspan="1">73.4 ± 10.0</td>
<td align="center" colspan="1" rowspan="1">&lt;0.001</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Heart rate, beats/min</td>
<td align="center" colspan="1" rowspan="1">71.9 ± 13.3</td>
<td align="center" colspan="1" rowspan="1">70.8 ± 13.4<a href="#tbl2fne" class="usa-link"><sup>e</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">72.4 ± 12.1</td>
<td align="center" colspan="1" rowspan="1">72.9 ± 12.4</td>
<td align="center" colspan="1" rowspan="1">0.027</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Blood biomarkers</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> NAC stage</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">&lt;0.001</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> 1</td>
<td align="center" colspan="1" rowspan="1">374 (69.9)<a href="#tbl2fna" class="usa-link"><sup>a</sup></a><sup>,</sup><a href="#tbl2fnb" class="usa-link"><sup>b</sup></a><sup>,</sup><a href="#tbl2fnc" class="usa-link"><sup>c</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">307 (57.4)<a href="#tbl2fnd" class="usa-link"><sup>d</sup></a><sup>,</sup><a href="#tbl2fne" class="usa-link"><sup>e</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">237 (44.2)<a href="#tbl2fnf" class="usa-link"><sup>f</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">177 (33.1)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> 2</td>
<td align="center" colspan="1" rowspan="1">127 (23.7)<a href="#tbl2fna" class="usa-link"><sup>a</sup></a><sup>,</sup><a href="#tbl2fnb" class="usa-link"><sup>b</sup></a><sup>,</sup><a href="#tbl2fnc" class="usa-link"><sup>c</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">176 (32.9)<a href="#tbl2fne" class="usa-link"><sup>e</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">219 (40.9)</td>
<td align="center" colspan="1" rowspan="1">210 (39.9)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> 3</td>
<td align="center" colspan="1" rowspan="1">34 (6.4)<a href="#tbl2fnb" class="usa-link"><sup>b</sup></a><sup>,</sup><a href="#tbl2fnc" class="usa-link"><sup>c</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">52 (9.7)<a href="#tbl2fne" class="usa-link"><sup>e</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">80 (14.9)<a href="#tbl2fnf" class="usa-link"><sup>f</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">148 (27.7)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> NT-proBNP, ng/L</td>
<td align="center" colspan="1" rowspan="1">1,725 (872-3,087)<a href="#tbl2fna" class="usa-link"><sup>a</sup></a><sup>,</sup><a href="#tbl2fnb" class="usa-link"><sup>b</sup></a><sup>,</sup><a href="#tbl2fnc" class="usa-link"><sup>c</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">2,384 (1,159-3,826)<a href="#tbl2fnd" class="usa-link"><sup>d</sup></a><sup>,</sup><a href="#tbl2fne" class="usa-link"><sup>e</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">3,554 (1,662-4,971)<a href="#tbl2fnf" class="usa-link"><sup>f</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">3,594 (2,031-6,792)</td>
<td align="center" colspan="1" rowspan="1">&lt;0.001</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> eGFR, mL/min/1.73 m<sup>2</sup>
</td>
<td align="center" colspan="1" rowspan="1">66 (55-80)<a href="#tbl2fna" class="usa-link"><sup>a</sup></a><sup>,</sup><a href="#tbl2fnb" class="usa-link"><sup>b</sup></a><sup>,</sup><a href="#tbl2fnc" class="usa-link"><sup>c</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">61 (51-74)<a href="#tbl2fnd" class="usa-link"><sup>d</sup></a><sup>,</sup><a href="#tbl2fne" class="usa-link"><sup>e</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">59 (46-71)<a href="#tbl2fnf" class="usa-link"><sup>f</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">51 (40-66)</td>
<td align="center" colspan="1" rowspan="1">&lt;0.001</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Hemoglobin, g/L</td>
<td align="center" colspan="1" rowspan="1">143 (134-151)<a href="#tbl2fna" class="usa-link"><sup>a</sup></a><sup>,</sup><a href="#tbl2fnb" class="usa-link"><sup>b</sup></a><sup>,</sup><a href="#tbl2fnc" class="usa-link"><sup>c</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">139 (130-148)<a href="#tbl2fnd" class="usa-link"><sup>d</sup></a><sup>,</sup><a href="#tbl2fne" class="usa-link"><sup>e</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">136 (125-146)<a href="#tbl2fnf" class="usa-link"><sup>f</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">131 (119-142)</td>
<td align="center" colspan="1" rowspan="1">&lt;0.001</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Serum total bilirubin, μmol/L</td>
<td align="center" colspan="1" rowspan="1">13 (9-18)</td>
<td align="center" colspan="1" rowspan="1">13 (9-17)</td>
<td align="center" colspan="1" rowspan="1">13 (9-20)</td>
<td align="center" colspan="1" rowspan="1">13 (9-19)</td>
<td align="center" colspan="1" rowspan="1">0.109</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Alanine transaminase, IU/L</td>
<td align="center" colspan="1" rowspan="1">27 (21-35)<a href="#tbl2fna" class="usa-link"><sup>a</sup></a><sup>,</sup><a href="#tbl2fnb" class="usa-link"><sup>b</sup></a><sup>,</sup><a href="#tbl2fnc" class="usa-link"><sup>c</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">25 (19-32)<a href="#tbl2fne" class="usa-link"><sup>e</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">25 (19-33)<a href="#tbl2fnf" class="usa-link"><sup>f</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">23 (18-31)</td>
<td align="center" colspan="1" rowspan="1">&lt;0.001</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Alkaline phosphatase, IU/L</td>
<td align="center" colspan="1" rowspan="1">83 (68-102)<a href="#tbl2fna" class="usa-link"><sup>a</sup></a><sup>,</sup><a href="#tbl2fnb" class="usa-link"><sup>b</sup></a><sup>,</sup><a href="#tbl2fnc" class="usa-link"><sup>c</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">88 (70-115)<a href="#tbl2fnd" class="usa-link"><sup>d</sup></a><sup>,</sup><a href="#tbl2fne" class="usa-link"><sup>e</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">96 (74-125)</td>
<td align="center" colspan="1" rowspan="1">101 (76-139)</td>
<td align="center" colspan="1" rowspan="1">&lt;0.001</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> GGT, IU/L</td>
<td align="center" colspan="1" rowspan="1">57 (29-113)<a href="#tbl2fna" class="usa-link"><sup>a</sup></a><sup>,</sup><a href="#tbl2fnb" class="usa-link"><sup>b</sup></a><sup>,</sup><a href="#tbl2fnc" class="usa-link"><sup>c</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">59 (30-115)<a href="#tbl2fne" class="usa-link"><sup>e</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">71 (35-139)</td>
<td align="center" colspan="1" rowspan="1">82 (36-176)</td>
<td align="center" colspan="1" rowspan="1">&lt;0.001</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Echocardiographic parameters</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> IVSd, mm</td>
<td align="center" colspan="1" rowspan="1">16.7 ± 2.7</td>
<td align="center" colspan="1" rowspan="1">16.8 ± 2.7</td>
<td align="center" colspan="1" rowspan="1">16.9 ± 2.5</td>
<td align="center" colspan="1" rowspan="1">16.8 ± 2.4</td>
<td align="center" colspan="1" rowspan="1">0.485</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> PWTd, mm</td>
<td align="center" colspan="1" rowspan="1">16.2 ± 2.8</td>
<td align="center" colspan="1" rowspan="1">16.3 ± 2.5</td>
<td align="center" colspan="1" rowspan="1">16.4 ± 2.7</td>
<td align="center" colspan="1" rowspan="1">16.3 ± 2.5</td>
<td align="center" colspan="1" rowspan="1">0.429</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> LVEF, %</td>
<td align="center" colspan="1" rowspan="1">50.5 ± 10.5<a href="#tbl2fnb" class="usa-link"><sup>b</sup></a><sup>,</sup><a href="#tbl2fnc" class="usa-link"><sup>c</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">50.0 ± 10.5<a href="#tbl2fnd" class="usa-link"><sup>d</sup></a><sup>,</sup><a href="#tbl2fne" class="usa-link"><sup>e</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">48.2 ± 10.8</td>
<td align="center" colspan="1" rowspan="1">47.3 ± 10.7</td>
<td align="center" colspan="1" rowspan="1">&lt;0.001</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Longitudinal strain, %</td>
<td align="center" colspan="1" rowspan="1">–11.9 ± 4.0<a href="#tbl2fnb" class="usa-link"><sup>b</sup></a><sup>,</sup><a href="#tbl2fnc" class="usa-link"><sup>c</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">–11.8 ± 3.8<a href="#tbl2fnd" class="usa-link"><sup>d</sup></a><sup>,</sup><a href="#tbl2fne" class="usa-link"><sup>e</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">–10.8 ± 3.8</td>
<td align="center" colspan="1" rowspan="1">–10.5 ± 3.6</td>
<td align="center" colspan="1" rowspan="1">&lt;0.001</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> E/e′</td>
<td align="center" colspan="1" rowspan="1">14.6 ± 6.8<a href="#tbl2fna" class="usa-link"><sup>a</sup></a><sup>,</sup><a href="#tbl2fnb" class="usa-link"><sup>b</sup></a><sup>,</sup><a href="#tbl2fnc" class="usa-link"><sup>c</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">16.5 ± 7.9<a href="#tbl2fne" class="usa-link"><sup>e</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">17.2 ± 6.7</td>
<td align="center" colspan="1" rowspan="1">17.6 ± 7.1</td>
<td align="center" colspan="1" rowspan="1">&lt;0.001</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tbl2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="tspara0030"><p>Values are mean ± SD, n (%), n, or median (Q1-Q3). <em>P</em> values for pairwise comparison.</p></div>
<div class="fn" id="tspara0035"><p>Abbreviations as in <a href="#tbl1" class="usa-link">Table 1</a>.</p></div>
<div class="fn" id="tbl2fna">
<sup>a</sup><p class="display-inline" id="ntpara0025"><em>P</em> &lt; 0.05 for &gt;426 m vs 347-426 m.</p>
</div>
<div class="fn" id="tbl2fnb">
<sup>b</sup><p class="display-inline" id="ntpara0030"><em>P</em> &lt; 0.05 for &gt;426 m vs 250-346 m.</p>
</div>
<div class="fn" id="tbl2fnc">
<sup>c</sup><p class="display-inline" id="ntpara0035"><em>P</em> &lt; 0.05 for &gt;426 m vs &lt;250 m.</p>
</div>
<div class="fn" id="tbl2fnd">
<sup>d</sup><p class="display-inline" id="ntpara0040"><em>P</em> &lt; 0.05 for 347-426 m vs 250-346 m.</p>
</div>
<div class="fn" id="tbl2fne">
<sup>e</sup><p class="display-inline" id="ntpara0045"><em>P</em> &lt; 0.05 for 347-426 m vs &lt;250 m.</p>
</div>
<div class="fn" id="tbl2fnf">
<sup>f</sup><p class="display-inline" id="ntpara0050"><em>P</em> &lt; 0.05 for 250-346 m vs &lt;250 m.</p>
</div>
</div></section><section class="tw xbox font-sm" id="tbl3"><h4 class="obj_head">Table 3.</h4>
<div class="caption p"><p>Baseline Characteristics for Patients Diagnosed With ATTR-CA Divided by the Percent Predicted 6MWT Distance Quartile</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr>
<th rowspan="2" colspan="1"></th>
<th colspan="4" rowspan="1">6MWT Percent Predicted Quartiles<hr>
</th>
<th rowspan="2" colspan="1">
<em>P</em> Value</th>
</tr>
<tr>
<th colspan="1" rowspan="1">&gt;89% (n = 546)</th>
<th colspan="1" rowspan="1">75%-89% (n = 522)</th>
<th colspan="1" rowspan="1">55%-74% (n = 546)</th>
<th colspan="1" rowspan="1">&lt;55% (n = 527)</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="1" rowspan="1">Baseline characteristics</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Age, y</td>
<td align="center" colspan="1" rowspan="1">75.9 ± 7.9<a href="#tbl3fnc" class="usa-link"><sup>c</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">75.6 ± 8.5<a href="#tbl3fne" class="usa-link"><sup>e</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">76.1 ± 9.1<a href="#tbl3fnf" class="usa-link"><sup>f</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">78.3 ± 7.8</td>
<td align="center" colspan="1" rowspan="1">&lt;0.001</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Male</td>
<td align="center" colspan="1" rowspan="1">491 (89.8)<a href="#tbl3fnc" class="usa-link"><sup>c</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">468 (89.7)<a href="#tbl3fne" class="usa-link"><sup>e</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">496 (90.8)<a href="#tbl3fnf" class="usa-link"><sup>f</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">430 (81.6)</td>
<td align="center" colspan="1" rowspan="1">&lt;0.001</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Ethnicity</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">&lt;0.001</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> White</td>
<td align="center" colspan="1" rowspan="1">474 (86.8)<a href="#tbl3fnc" class="usa-link"><sup>c</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">455 (87.2)<a href="#tbl3fne" class="usa-link"><sup>e</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">444 (81.3)<a href="#tbl3fnf" class="usa-link"><sup>f</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">386 (73.2)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Afro-Caribbean</td>
<td align="center" colspan="1" rowspan="1">65 (11.9)<a href="#tbl3fnb" class="usa-link"><sup>b</sup></a><sup>,</sup><a href="#tbl3fnc" class="usa-link"><sup>c</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">60 (11.5)<a href="#tbl3fnd" class="usa-link"><sup>d</sup></a><sup>,</sup><a href="#tbl3fne" class="usa-link"><sup>e</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">96 (17.6)<a href="#tbl3fnf" class="usa-link"><sup>f</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">132 (25.0)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Asian</td>
<td align="center" colspan="1" rowspan="1">4 (0.7)</td>
<td align="center" colspan="1" rowspan="1">6 (1.1)</td>
<td align="center" colspan="1" rowspan="1">5 (0.9)</td>
<td align="center" colspan="1" rowspan="1">6 (1.1)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Other</td>
<td align="center" colspan="1" rowspan="1">3 (0.5)</td>
<td align="center" colspan="1" rowspan="1">1 (0.2)</td>
<td align="center" colspan="1" rowspan="1">1 (0.2)</td>
<td align="center" colspan="1" rowspan="1">3 (0.6)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Genotypes</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">&lt;0.001</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> wtATTR</td>
<td align="center" colspan="1" rowspan="1">431 (78.9)<a href="#tbl3fnc" class="usa-link"><sup>c</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">396 (75.9)<a href="#tbl3fne" class="usa-link"><sup>e</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">402 (73.6)<a href="#tbl3fnf" class="usa-link"><sup>f</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">344 (65.3)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> p.(V142I) hATTR</td>
<td align="center" colspan="1" rowspan="1">52 (9.5)<a href="#tbl3fnc" class="usa-link"><sup>c</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">48 (9.2)<a href="#tbl3fne" class="usa-link"><sup>e</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">77 (14.2)<a href="#tbl3fnf" class="usa-link"><sup>f</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">115 (21.8)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Non-p.(V142I) hATTR</td>
<td align="center" colspan="1" rowspan="1">63 (11.5)</td>
<td align="center" colspan="1" rowspan="1">78 (14.9)</td>
<td align="center" colspan="1" rowspan="1">67 (12.3)</td>
<td align="center" colspan="1" rowspan="1">68 (12.9)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1">Heart failure severity</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> NYHA functional class</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">&lt;0.001</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> I</td>
<td align="center" colspan="1" rowspan="1">126 (23.1)<a href="#tbl3fna" class="usa-link"><sup>a</sup></a><sup>,</sup><a href="#tbl3fnb" class="usa-link"><sup>b</sup></a><sup>,</sup><a href="#tbl3fnc" class="usa-link"><sup>c</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">71 (13.6)<a href="#tbl3fnd" class="usa-link"><sup>d</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">52 (9.5)</td>
<td align="center" colspan="1" rowspan="1">33 (6.3)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> II</td>
<td align="center" colspan="1" rowspan="1">372 (68.1)<a href="#tbl3fnc" class="usa-link"><sup>c</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">343 (65.7)<a href="#tbl3fne" class="usa-link"><sup>e</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">371 (67.9)<a href="#tbl3fnf" class="usa-link"><sup>f</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">282 (53.5)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> III</td>
<td align="center" colspan="1" rowspan="1">32 (5.8)<a href="#tbl3fna" class="usa-link"><sup>a</sup></a><sup>,</sup><a href="#tbl3fnb" class="usa-link"><sup>b</sup></a><sup>,</sup><a href="#tbl3fnc" class="usa-link"><sup>c</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">56 (10.7)<a href="#tbl3fne" class="usa-link"><sup>e</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">78 (14.2)<a href="#tbl3fnf" class="usa-link"><sup>f</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">167 (31.7)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> IV</td>
<td align="center" colspan="1" rowspan="1">0 (0.0)<a href="#tbl3fnc" class="usa-link"><sup>c</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">0 (0.0)<a href="#tbl3fne" class="usa-link"><sup>e</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">3 (0.5)</td>
<td align="center" colspan="1" rowspan="1">10 (1.9)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Missing</td>
<td align="center" colspan="1" rowspan="1">16</td>
<td align="center" colspan="1" rowspan="1">52</td>
<td align="center" colspan="1" rowspan="1">42</td>
<td align="center" colspan="1" rowspan="1">35</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> 6MWT distance, m</td>
<td align="center" colspan="1" rowspan="1">460 (414-515)<a href="#tbl3fna" class="usa-link"><sup>a</sup></a><sup>,</sup><a href="#tbl3fnb" class="usa-link"><sup>b</sup></a><sup>,</sup><a href="#tbl3fnc" class="usa-link"><sup>c</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">391 (351-432)<a href="#tbl3fnd" class="usa-link"><sup>d</sup></a><sup>,</sup><a href="#tbl3fne" class="usa-link"><sup>e</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">310 (276-349)<a href="#tbl3fnf" class="usa-link"><sup>f</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">161 (92-211)</td>
<td align="center" colspan="1" rowspan="1">&lt;0.001</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Systolic blood pressure, mm Hg</td>
<td align="center" colspan="1" rowspan="1">128.3 ± 17.3<a href="#tbl3fnb" class="usa-link"><sup>b</sup></a><sup>,</sup><a href="#tbl3fnc" class="usa-link"><sup>c</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">126.0 ± 17.1</td>
<td align="center" colspan="1" rowspan="1">125.2 ± 16.8</td>
<td align="center" colspan="1" rowspan="1">123.9 ± 17.8</td>
<td align="center" colspan="1" rowspan="1">&lt;0.001</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Diastolic blood pressure, mm Hg</td>
<td align="center" colspan="1" rowspan="1">76.0 ± 9.9<a href="#tbl3fnc" class="usa-link"><sup>c</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">75.4 ± 10.5<a href="#tbl3fne" class="usa-link"><sup>e</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">75.0 ± 10.2</td>
<td align="center" colspan="1" rowspan="1">73.5 ± 10.0</td>
<td align="center" colspan="1" rowspan="1">0.001</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Heart rate, beats/min</td>
<td align="center" colspan="1" rowspan="1">70.1 ± 13.5<a href="#tbl3fnb" class="usa-link"><sup>b</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">71.9 ± 12.7</td>
<td align="center" colspan="1" rowspan="1">72.9 ± 12.7</td>
<td align="center" colspan="1" rowspan="1">72.5 ± 12.4</td>
<td align="center" colspan="1" rowspan="1">0.011</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Blood biomarkers</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> NAC stage</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">&lt;0.001</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> 1</td>
<td align="center" colspan="1" rowspan="1">365 (66.8)<a href="#tbl3fna" class="usa-link"><sup>a</sup></a><sup>,</sup><a href="#tbl3fnb" class="usa-link"><sup>b</sup></a><sup>,</sup><a href="#tbl3fnc" class="usa-link"><sup>c</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">287 (55.0)<a href="#tbl3fne" class="usa-link"><sup>e</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">265 (48.5)<a href="#tbl3fnf" class="usa-link"><sup>f</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">178 (33.8)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> 2</td>
<td align="center" colspan="1" rowspan="1">131 (24.0)<a href="#tbl3fna" class="usa-link"><sup>a</sup></a><sup>,</sup><a href="#tbl3fnb" class="usa-link"><sup>b</sup></a><sup>,</sup><a href="#tbl3fnc" class="usa-link"><sup>c</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">184 (35.2)</td>
<td align="center" colspan="1" rowspan="1">210 (38.5)</td>
<td align="center" colspan="1" rowspan="1">207 (39.3)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> 3</td>
<td align="center" colspan="1" rowspan="1">50 (9.2)<a href="#tbl3fnc" class="usa-link"><sup>c</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">51 (9.8)<a href="#tbl3fne" class="usa-link"><sup>e</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">71 (13.0)<a href="#tbl3fnf" class="usa-link"><sup>f</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">142 (26.9)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> NT-proBNP, ng/L</td>
<td align="center" colspan="1" rowspan="1">1,785 (940-3,281)<a href="#tbl3fna" class="usa-link"><sup>a</sup></a><sup>,</sup><a href="#tbl3fnb" class="usa-link"><sup>b</sup></a><sup>,</sup><a href="#tbl3fnc" class="usa-link"><sup>c</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">2,476 (1,311-4,134)<a href="#tbl3fne" class="usa-link"><sup>e</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">2,764 (1,357-4,796)<a href="#tbl3fnf" class="usa-link"><sup>f</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">3,577 (2,009-6,475)</td>
<td align="center" colspan="1" rowspan="1">&lt;0.001</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> eGFR, mL/min/1.73 m<sup>2</sup>
</td>
<td align="center" colspan="1" rowspan="1">63 (53-78)<a href="#tbl3fnb" class="usa-link"><sup>b</sup></a><sup>,</sup><a href="#tbl3fnc" class="usa-link"><sup>c</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">63 (50-72)<a href="#tbl3fne" class="usa-link"><sup>e</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">59 (48-74)<a href="#tbl3fnf" class="usa-link"><sup>f</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">52 (40-66)</td>
<td align="center" colspan="1" rowspan="1">&lt;0.001</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Hemoglobin, g/L</td>
<td align="center" colspan="1" rowspan="1">142 (132-151)<a href="#tbl3fnb" class="usa-link"><sup>b</sup></a><sup>,</sup><a href="#tbl3fnc" class="usa-link"><sup>c</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">140 (129-149)<a href="#tbl3fnd" class="usa-link"><sup>d</sup></a><sup>,</sup><a href="#tbl3fne" class="usa-link"><sup>e</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">137 (126-146)<a href="#tbl3fnf" class="usa-link"><sup>f</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">132 (120-143)</td>
<td align="center" colspan="1" rowspan="1">&lt;0.001</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Serum total bilirubin, μmol/L</td>
<td align="center" colspan="1" rowspan="1">12 (9-17)<a href="#tbl3fnb" class="usa-link"><sup>b</sup></a><sup>,</sup><a href="#tbl3fnc" class="usa-link"><sup>c</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">13 (9-18)</td>
<td align="center" colspan="1" rowspan="1">13 (9-19)</td>
<td align="center" colspan="1" rowspan="1">13 (9-19)</td>
<td align="center" colspan="1" rowspan="1">0.005</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Alanine transaminase, IU/L</td>
<td align="center" colspan="1" rowspan="1">26 (20-34)<a href="#tbl3fnc" class="usa-link"><sup>c</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">25 (19-34)<a href="#tbl3fne" class="usa-link"><sup>e</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">25 (19-32)</td>
<td align="center" colspan="1" rowspan="1">24 (18-31)</td>
<td align="center" colspan="1" rowspan="1">&lt;0.001</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Alkaline phosphatase, IU/L</td>
<td align="center" colspan="1" rowspan="1">83 (68-105)<a href="#tbl3fnb" class="usa-link"><sup>b</sup></a><sup>,</sup><a href="#tbl3fnc" class="usa-link"><sup>c</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">89 (70-114)<a href="#tbl3fnd" class="usa-link"><sup>d</sup></a><sup>,</sup><a href="#tbl3fne" class="usa-link"><sup>e</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">93 (73-125)</td>
<td align="center" colspan="1" rowspan="1">101 (76-140)</td>
<td align="center" colspan="1" rowspan="1">&lt;0.001</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> GGT, IU/L</td>
<td align="center" colspan="1" rowspan="1">54 (28-105)<a href="#tbl3fnb" class="usa-link"><sup>b</sup></a><sup>,</sup><a href="#tbl3fnc" class="usa-link"><sup>c</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">65 (32-118)<a href="#tbl3fne" class="usa-link"><sup>e</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">70 (32-143)<a href="#tbl3fnf" class="usa-link"><sup>f</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">84 (38-185)</td>
<td align="center" colspan="1" rowspan="1">&lt;0.001</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Echocardiographic parameters</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> IVSd, mm</td>
<td align="center" colspan="1" rowspan="1">16.6 ± 2.6</td>
<td align="center" colspan="1" rowspan="1">17.0 ± 2.7</td>
<td align="center" colspan="1" rowspan="1">16.8 ± 2.6</td>
<td align="center" colspan="1" rowspan="1">16.7 ± 2.4</td>
<td align="center" colspan="1" rowspan="1">0.035</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> PWTd, mm</td>
<td align="center" colspan="1" rowspan="1">16.1 ± 2.7</td>
<td align="center" colspan="1" rowspan="1">16.5 ± 2.6</td>
<td align="center" colspan="1" rowspan="1">16.4 ± 2.7</td>
<td align="center" colspan="1" rowspan="1">16.3 ± 2.5</td>
<td align="center" colspan="1" rowspan="1">0.048</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> LVEF, %</td>
<td align="center" colspan="1" rowspan="1">51.2 ± 10.2<a href="#tbl3fna" class="usa-link"><sup>a</sup></a><sup>,</sup><a href="#tbl3fnb" class="usa-link"><sup>b</sup></a><sup>,</sup><a href="#tbl3fnc" class="usa-link"><sup>c</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">49.0 ± 10.5<a href="#tbl3fne" class="usa-link"><sup>e</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">48.5 ± 11.0</td>
<td align="center" colspan="1" rowspan="1">47.1 ± 10.7</td>
<td align="center" colspan="1" rowspan="1">&lt;0.001</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Longitudinal strain, %</td>
<td align="center" colspan="1" rowspan="1">–12.0 ± 4.0<a href="#tbl3fnb" class="usa-link"><sup>b</sup></a><sup>,</sup><a href="#tbl3fnc" class="usa-link"><sup>c</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">–11.5 ± 3.8<a href="#tbl3fne" class="usa-link"><sup>e</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">–11.0 ± 3.8</td>
<td align="center" colspan="1" rowspan="1">–10.4 ± 3.6</td>
<td align="center" colspan="1" rowspan="1">&lt;0.001</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> E/e′</td>
<td align="center" colspan="1" rowspan="1">15.3 ± 7.1<a href="#tbl3fna" class="usa-link"><sup>a</sup></a><sup>,</sup><a href="#tbl3fnb" class="usa-link"><sup>b</sup></a><sup>,</sup><a href="#tbl3fnc" class="usa-link"><sup>c</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">16.5 ± 6.6<a href="#tbl3fne" class="usa-link"><sup>e</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">17.0 ± 7.9</td>
<td align="center" colspan="1" rowspan="1">17.1 ± 7.0</td>
<td align="center" colspan="1" rowspan="1">&lt;0.001</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tbl3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="tspara0045"><p>Values are mean ± SD, n (%), n, or median (Q1-Q3). <em>P</em> values for pairwise comparison.</p></div>
<div class="fn" id="tspara0050"><p>Abbreviations as in <a href="#tbl1" class="usa-link">Table 1</a>.</p></div>
<div class="fn" id="tbl3fna">
<sup>a</sup><p class="display-inline" id="ntpara0055"><em>P</em> &lt; 0.05 for &gt;89% vs 75%-89%.</p>
</div>
<div class="fn" id="tbl3fnb">
<sup>b</sup><p class="display-inline" id="ntpara0060"><em>P</em> &lt; 0.05 for &gt;89% vs 55%-74%.</p>
</div>
<div class="fn" id="tbl3fnc">
<sup>c</sup><p class="display-inline" id="ntpara0065"><em>P</em> &lt; 0.05 for &gt;89% vs &lt;55%.</p>
</div>
<div class="fn" id="tbl3fnd">
<sup>d</sup><p class="display-inline" id="ntpara0070"><em>P</em> &lt; 0.05 for 75%-89% vs 55%-74%.</p>
</div>
<div class="fn" id="tbl3fne">
<sup>e</sup><p class="display-inline" id="ntpara0075"><em>P</em> &lt; 0.05 for 75%-89% vs &lt;55%.</p>
</div>
<div class="fn" id="tbl3fnf">
<sup>f</sup><p class="display-inline" id="ntpara0080"><em>P</em> &lt; 0.05 for 55%-74% vs &lt;55%.</p>
</div>
</div></section></section><section id="sec2.2"><h3 class="pmc_sec_title">Worsening 6-MWT at 1 year</h3>
<p id="p0090">At 1 year, 1,118 patients had a repeat 6MWT. The median absolute reduction in 6MWT distance was 17 m, and the mean relative percent reduction was 4.5%. The median absolute reduction was greater in patients with p.(V142I) hATTR and those with non-p.(V142I) hATTR than in patients with wtATTR-CA (33 m vs 33 m vs 13 m; <em>P</em> &lt; 0.001), and a similar trend was observed when comparing the mean relative percent reduction across genotypes (9.3% vs 7.9% vs 3.2%; <em>P</em> &lt; 0.001).</p>
<p id="p0095">At 1 year, 365 (32.7%) patients experienced NT-proBNP progression (defined as an increase of &gt;700 ng/L and &gt;30%). Patients who experienced NT-proBNP progression had a greater decline in 6MWT distance than those with a stable NT-proBNP, whereby the difference in the mean 6MWT distance (adjusted for baseline 6MWT distance) between the 2 groups was –37.8 m (95% CI: –48.3 to –27.4 m; <em>P</em> &lt; 0.001). This relationship was maintained when NT-proBNP was assessed as a continuous variable (<a href="#mmc1" class="usa-link">Supplemental Appendix</a>). At 1 year, 303 (27.1%) patients experienced ODI. Patients who experienced ODI also had a greater decline in 6MWT distance than those with a stable diuretic dosage, with an adjusted mean difference of –24.5 m (95% CI: –35.7 to –13.3 m; <em>P</em> &lt; 0.001). A similar trend was observed in the assessment of the change in percent predicted 6MWT distance (NT-proBNP progression: –8.4%; 95% CI: –10.6% to –6.1%; <em>P</em> &lt; 0.001; ODI: –5.1%; 95% CI: –7.5% to –2.7%; <em>P</em> &lt; 0.001). To assess whether the magnitude of 6MWT decline changed over time, patients were divided into historical (pre-2017: n = 604) and contemporary cohorts (post-2017: n = 514). Patients in the historical cohort had a more advanced cardiac phenotype at diagnosis (<a href="#mmc1" class="usa-link">Supplemental Table 1</a>) and experienced a greater decline in the absolute 6MWT distance than those in the contemporary cohort (median reduction: 23 m vs 11 m; <em>P</em> = 0.004), with an adjusted mean difference of –17.1 m (95% CI: –27.2 to –7.0 m; <em>P</em> = 0.001). A similar trend was observed in the assessment of the percent predicted 6MWT distance (–4.5%; 95% CI: –2.3% to –6.7%; <em>P</em> &lt; 0.001). These variables alongside hATTR-CA and log NT-proBNP remained independently associated with a decline in the absolute 6MWT distance and percent predicted 6MWT distance in a multivariable linear regression model (<a href="#mmc1" class="usa-link">Supplemental Table 2</a>).</p>
<p id="p0100">Worsening of the 6MWT distance was also assessed as an absolute worsening (reduction of &gt;35 m) and a relative worsening (reduction of &gt;5%). At 1 year, 429 (38.4%) patients experienced an absolute worsening of the 6MWT, and 548 (49.0%) experienced a relative worsening of the 6MWT. Patients who experienced worsening more commonly had the p.(V142I) or non-p.(V142I) genotype than wtATTR-CA, a lower eGFR level, and a lower hemoglobin level (<a href="#tbl4" class="usa-link">Table 4</a>). Patients in the historical cohort more commonly experienced an absolute (258 [42.7%] vs 171 [33.3%]; <em>P</em> = 0.001) and relative worsening (320 [53.0%] vs 228 [44.4%]; <em>P</em> = 0.004) of the 6MWT distance.</p>
<section class="tw xbox font-sm" id="tbl4"><h4 class="obj_head">Table 4.</h4>
<div class="caption p"><p>Baseline Characteristics for Patients Who Experienced an Absolute and Relative Reduction in the 6MWT Distance Compared to Those Who Did Not</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr>
<th rowspan="2" colspan="1"></th>
<th colspan="3" rowspan="1">Absolute Reduction in 6MWT Distance<hr>
</th>
<th colspan="3" rowspan="1">Relative Reduction in 6MWT Distance<hr>
</th>
</tr>
<tr>
<th colspan="1" rowspan="1">Stable Distance (n = 689; 61.6%)</th>
<th colspan="1" rowspan="1">Reduction &gt;35 m (n = 429; = 38.4%)</th>
<th colspan="1" rowspan="1">
<em>P</em> Value</th>
<th colspan="1" rowspan="1">Stable Distance (n = 570; 51.0%)</th>
<th colspan="1" rowspan="1">Reduction &gt;5% (n = 548; 49.0%)</th>
<th colspan="1" rowspan="1">
<em>P</em> Value</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="1" rowspan="1">Baseline characteristics</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Age, y</td>
<td align="center" colspan="1" rowspan="1">75.5 ± 8.5</td>
<td align="center" colspan="1" rowspan="1">74.7 ± 8.2</td>
<td align="center" colspan="1" rowspan="1">0.038</td>
<td align="center" colspan="1" rowspan="1">75.0 ± 8.8</td>
<td align="center" colspan="1" rowspan="1">75.3 ± 8.1</td>
<td align="center" colspan="1" rowspan="1">0.957</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Male</td>
<td align="center" colspan="1" rowspan="1">621 (90.1)</td>
<td align="center" colspan="1" rowspan="1">375 (87.4)</td>
<td align="center" colspan="1" rowspan="1">0.156</td>
<td align="center" colspan="1" rowspan="1">513 (90.0)</td>
<td align="center" colspan="1" rowspan="1">483 (88.1)</td>
<td align="center" colspan="1" rowspan="1">0.318</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Ethnicity</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">0.010</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">0.005</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> White</td>
<td align="center" colspan="1" rowspan="1">574 (83.3)</td>
<td align="center" colspan="1" rowspan="1">83 (19.3)</td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">482 (84.6)<a href="#tbl4fna" class="usa-link"><sup>a</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">432 (78.8)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Afro-Caribbean</td>
<td align="center" colspan="1" rowspan="1">106 (15.4)</td>
<td align="center" colspan="1" rowspan="1">83 (19.3)</td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">80 (14.0)<a href="#tbl4fna" class="usa-link"><sup>a</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">109 (19.9)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Asian</td>
<td align="center" colspan="1" rowspan="1">9 (1.3)</td>
<td align="center" colspan="1" rowspan="1">2 (0.5)</td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">8 (1.4)</td>
<td align="center" colspan="1" rowspan="1">3 (0.5)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Other</td>
<td align="center" colspan="1" rowspan="1">0 (0.0)<a href="#tbl4fna" class="usa-link"><sup>a</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">4 (0.9)</td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">8 (1.4)<a href="#tbl4fna" class="usa-link"><sup>a</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">3 (0.5)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Genotypes</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">&lt;0.001</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">0.001</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> wtATTR</td>
<td align="center" colspan="1" rowspan="1">530 (76.9)<a href="#tbl4fna" class="usa-link"><sup>a</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">285 (66.4)</td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">443 (77.7)<a href="#tbl4fna" class="usa-link"><sup>a</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">372 (67.9)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> p.(V142I) hATTR</td>
<td align="center" colspan="1" rowspan="1">77 (11.2)<a href="#tbl4fna" class="usa-link"><sup>a</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">68 (15.9)</td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">60 (10.5)<a href="#tbl4fna" class="usa-link"><sup>a</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">85 (15.5)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Non-p.(V142I) hATTR</td>
<td align="center" colspan="1" rowspan="1">82 (11.9)<a href="#tbl4fna" class="usa-link"><sup>a</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">76 (17.7)</td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">67 (11.8)<a href="#tbl4fna" class="usa-link"><sup>a</sup></a>
</td>
<td align="center" colspan="1" rowspan="1">91 (16.6)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1">Heart failure severity</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> NYHA functional class</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">0.039</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">0.252</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> I</td>
<td align="center" colspan="1" rowspan="1">101 (14.7)</td>
<td align="center" colspan="1" rowspan="1">54 (12.6)</td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">87 (15.3)</td>
<td align="center" colspan="1" rowspan="1">68 (12.4)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> II</td>
<td align="center" colspan="1" rowspan="1">444 (64.4)</td>
<td align="center" colspan="1" rowspan="1">307 (71.6)<a href="#tbl4fna" class="usa-link"><sup>a</sup></a>
</td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">374 (65.6)</td>
<td align="center" colspan="1" rowspan="1">377 (68.8)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> III</td>
<td align="center" colspan="1" rowspan="1">125 (18.1)</td>
<td align="center" colspan="1" rowspan="1">61 (14.2)</td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">97 (17.0)</td>
<td align="center" colspan="1" rowspan="1">89 (16.2)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> IV</td>
<td align="center" colspan="1" rowspan="1">5 (0.7)</td>
<td align="center" colspan="1" rowspan="1">0 (0.0)</td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">1 (0.2)</td>
<td align="center" colspan="1" rowspan="1">4 (0.7)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Missing</td>
<td align="center" colspan="1" rowspan="1">14</td>
<td align="center" colspan="1" rowspan="1">7</td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">11</td>
<td align="center" colspan="1" rowspan="1">10</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Baseline 6MWT distance, m</td>
<td align="center" colspan="1" rowspan="1">365 (264-438)</td>
<td align="center" colspan="1" rowspan="1">385 (301-448)</td>
<td align="center" colspan="1" rowspan="1">0.005</td>
<td align="center" colspan="1" rowspan="1">372 (276-450)</td>
<td align="center" colspan="1" rowspan="1">368 (286-434)</td>
<td align="center" colspan="1" rowspan="1">0.842</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Baseline percent predicted 6MWT, %</td>
<td align="center" colspan="1" rowspan="1">72.1 ± 25.6</td>
<td align="center" colspan="1" rowspan="1">78.0 ± 22.2</td>
<td align="center" colspan="1" rowspan="1">0.004</td>
<td align="center" colspan="1" rowspan="1">73.3 ± 25.7</td>
<td align="center" colspan="1" rowspan="1">75.4 ± 23.3</td>
<td align="center" colspan="1" rowspan="1">0.630</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Systolic blood pressure, mm Hg</td>
<td align="center" colspan="1" rowspan="1">126.5 ± 17.0</td>
<td align="center" colspan="1" rowspan="1">124.5 ± 17.1</td>
<td align="center" colspan="1" rowspan="1">0.036</td>
<td align="center" colspan="1" rowspan="1">126.3 ± 16.8</td>
<td align="center" colspan="1" rowspan="1">125.0 ± 17.3</td>
<td align="center" colspan="1" rowspan="1">0.144</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Diastolic blood pressure, mm Hg</td>
<td align="center" colspan="1" rowspan="1">75.0 ± 10.0</td>
<td align="center" colspan="1" rowspan="1">73.9 ± 10.5</td>
<td align="center" colspan="1" rowspan="1">0.019</td>
<td align="center" colspan="1" rowspan="1">75.1 ± 10.0</td>
<td align="center" colspan="1" rowspan="1">74.0 ± 10.4</td>
<td align="center" colspan="1" rowspan="1">0.029</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Heart rate, beats/min</td>
<td align="center" colspan="1" rowspan="1">71.7 ± 12.8</td>
<td align="center" colspan="1" rowspan="1">72.8 ± 14.1</td>
<td align="center" colspan="1" rowspan="1">0.420</td>
<td align="center" colspan="1" rowspan="1">71.6 ± 12.9</td>
<td align="center" colspan="1" rowspan="1">72.7 ± 13.6</td>
<td align="center" colspan="1" rowspan="1">0.267</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Blood biomarkers</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> NAC stage</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">0.220</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">0.109</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> 1</td>
<td align="center" colspan="1" rowspan="1">404 (58.6)</td>
<td align="center" colspan="1" rowspan="1">229 (53.4)</td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">339 (59.5)</td>
<td align="center" colspan="1" rowspan="1">294 (53.6)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> 2</td>
<td align="center" colspan="1" rowspan="1">215 (31.2)</td>
<td align="center" colspan="1" rowspan="1">149 (34.7)</td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">177 (31.1)</td>
<td align="center" colspan="1" rowspan="1">187 (34.1)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> 3</td>
<td align="center" colspan="1" rowspan="1">70 (10.2)</td>
<td align="center" colspan="1" rowspan="1">51 (11.9)</td>
<td colspan="1" rowspan="1"></td>
<td align="center" colspan="1" rowspan="1">54 (9.5)</td>
<td align="center" colspan="1" rowspan="1">67 (12.2)</td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> NT-proBNP, ng/L</td>
<td align="center" colspan="1" rowspan="1">2,313 (1,115-4,030)</td>
<td align="center" colspan="1" rowspan="1">2,436 (1,281-4,224)</td>
<td align="center" colspan="1" rowspan="1">0.135</td>
<td align="center" colspan="1" rowspan="1">2,286 (1,073-3,958)</td>
<td align="center" colspan="1" rowspan="1">2,461 (1,281-4,263)</td>
<td align="center" colspan="1" rowspan="1">0.018</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> eGFR, mL/min/1.73 m<sup>2</sup>
</td>
<td align="center" colspan="1" rowspan="1">62 (52-77)</td>
<td align="center" colspan="1" rowspan="1">60 (48-74)</td>
<td align="center" colspan="1" rowspan="1">0.009</td>
<td align="center" colspan="1" rowspan="1">63 (52-77)</td>
<td align="center" colspan="1" rowspan="1">59 (48-74)</td>
<td align="center" colspan="1" rowspan="1">0.002</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Hemoglobin, g/L</td>
<td align="center" colspan="1" rowspan="1">140 (130-149)</td>
<td align="center" colspan="1" rowspan="1">137 (126-148)</td>
<td align="center" colspan="1" rowspan="1">0.006</td>
<td align="center" colspan="1" rowspan="1">141 (130-149)</td>
<td align="center" colspan="1" rowspan="1">137 (127-148)</td>
<td align="center" colspan="1" rowspan="1">0.005</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Serum total bilirubin, μmol/L</td>
<td align="center" colspan="1" rowspan="1">12 (9-18)</td>
<td align="center" colspan="1" rowspan="1">13 (9-18)</td>
<td align="center" colspan="1" rowspan="1">0.393</td>
<td align="center" colspan="1" rowspan="1">12 (9-17)</td>
<td align="center" colspan="1" rowspan="1">13 (9-18)</td>
<td align="center" colspan="1" rowspan="1">0.577</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Alanine transaminase, IU/L</td>
<td align="center" colspan="1" rowspan="1">25 (19-33)</td>
<td align="center" colspan="1" rowspan="1">25 (19-33)</td>
<td align="center" colspan="1" rowspan="1">0.865</td>
<td align="center" colspan="1" rowspan="1">25 (19-34)</td>
<td align="center" colspan="1" rowspan="1">25 (19-32)</td>
<td align="center" colspan="1" rowspan="1">0.544</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Alkaline phosphatase, IU/L</td>
<td align="center" colspan="1" rowspan="1">87 (69-114)</td>
<td align="center" colspan="1" rowspan="1">87 (68 -115)</td>
<td align="center" colspan="1" rowspan="1">0.967</td>
<td align="center" colspan="1" rowspan="1">87 (68-114)</td>
<td align="center" colspan="1" rowspan="1">87 (70-115)</td>
<td align="center" colspan="1" rowspan="1">0.517</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> GGT, IU/L</td>
<td align="center" colspan="1" rowspan="1">63 (30-129)</td>
<td align="center" colspan="1" rowspan="1">70 (33-134)</td>
<td align="center" colspan="1" rowspan="1">0.327</td>
<td align="center" colspan="1" rowspan="1">62 (31-129)</td>
<td align="center" colspan="1" rowspan="1">70 (32-133)</td>
<td align="center" colspan="1" rowspan="1">0.223</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Echocardiographic parameters</td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
</tr>
<tr>
<td colspan="1" rowspan="1"> IVSd, mm</td>
<td align="center" colspan="1" rowspan="1">16.6 ± 2.5</td>
<td align="center" colspan="1" rowspan="1">16.8 ± 2.5</td>
<td align="center" colspan="1" rowspan="1">0.111</td>
<td align="center" colspan="1" rowspan="1">16.6 ± 2.5</td>
<td align="center" colspan="1" rowspan="1">16.8 ± 2.5</td>
<td align="center" colspan="1" rowspan="1">0.112</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> PWTd, mm</td>
<td align="center" colspan="1" rowspan="1">16.2 ± 2.6</td>
<td align="center" colspan="1" rowspan="1">16.5 ± 2.6</td>
<td align="center" colspan="1" rowspan="1">0.074</td>
<td align="center" colspan="1" rowspan="1">16.1 ± 2.6</td>
<td align="center" colspan="1" rowspan="1">16.4 ± 2.6</td>
<td align="center" colspan="1" rowspan="1">0.074</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> LVEF, %</td>
<td align="center" colspan="1" rowspan="1">49.3 ± 10.6</td>
<td align="center" colspan="1" rowspan="1">49.5 ± 10.7</td>
<td align="center" colspan="1" rowspan="1">0.702</td>
<td align="center" colspan="1" rowspan="1">49.3 ± 10.7</td>
<td align="center" colspan="1" rowspan="1">49.5 ± 10.5</td>
<td align="center" colspan="1" rowspan="1">0.628</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> Longitudinal strain, %</td>
<td align="center" colspan="1" rowspan="1">–11.3 ± 3.7</td>
<td align="center" colspan="1" rowspan="1">–11.6 ± 3.6</td>
<td align="center" colspan="1" rowspan="1">0.181</td>
<td align="center" colspan="1" rowspan="1">–11.3 ± 3.7</td>
<td align="center" colspan="1" rowspan="1">–11.5 ± 3.6</td>
<td align="center" colspan="1" rowspan="1">0.495</td>
</tr>
<tr>
<td colspan="1" rowspan="1"> E/e′</td>
<td align="center" colspan="1" rowspan="1">15.8 ± 7.5</td>
<td align="center" colspan="1" rowspan="1">16.2 ± 6.5</td>
<td align="center" colspan="1" rowspan="1">0.171</td>
<td align="center" colspan="1" rowspan="1">15.6 ± 7.5</td>
<td align="center" colspan="1" rowspan="1">16.4 ± 6.7</td>
<td align="center" colspan="1" rowspan="1">0.010</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/tbl4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p">
<div class="fn" id="tspara0060"><p>Values are mean ± SD, n (%), n, or median (Q1-Q3).</p></div>
<div class="fn" id="tspara0065"><p>Abbreviations as in <a href="#tbl1" class="usa-link">Table 1</a>.</p></div>
<div class="fn" id="tbl4fna">
<sup>a</sup><p class="display-inline" id="ntpara0085"><em>P</em> values for pairwise comparison &lt; 0.05.</p>
</div>
</div></section></section><section id="sec2.3"><h3 class="pmc_sec_title">Survival</h3>
<section id="sec2.3.1"><h4 class="pmc_sec_title">Baseline 6MWT and risk stratification</h4>
<p id="p0105">At a median follow-up of 43.1 months (Q1-Q3: 14.2-60.0 months), analysis by baseline 6MWT distance quartiles demonstrated a significant increase in death rate with each reduction in 6MWT distance. Compared with patients who walked &gt;427 m, in whom the death rate was 6.3 deaths per 100 person-years (py) (95% CI: 5.3-7.6 deaths per 100 py), the death rate was 9.2 deaths per 100 py (95% CI: 7.8-10.7 deaths per 100 py) in patients who walked 347 to 426 m, 13.6 deaths per 100 py (95% CI: 11.9-15.6 deaths per 100 py) in patients who walked 250 to 346 m, and 19.0 deaths per 100 py (95% CI: 16.9-21.3 deaths per 100 py) in patients who walked &lt;250 m. Analysis by percent predicted 6MWT distance demonstrated a similar incremental increase in mortality (<a href="#fig1" class="usa-link">Figure 1</a>).</p>
<figure class="fig xbox font-sm" id="fig1"><h5 class="obj_head">Figure 1.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11218050_gr1.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0e3/11218050/dd31e4c07aa4/gr1.jpg" loading="lazy" height="973" width="716" alt="Figure 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Baseline 6-Minute Walk Test Quartiles and Survival</p>
<p>Kaplan-Meier curves demonstrating the effect of (A) 6-minute walk test distance quartile and (B) percent predicted 6-minute walk test quartile on survival.</p></figcaption></figure><p id="p0110">In the overall population, the 6MWT distance was associated with survival (HR: 0.98 for every 10-m increase; 95% CI: 0.97-0.99 for every 10-m increase; <em>P</em> &lt; 0.001). Patients with a baseline 6MWT distance of &lt;350 m had a higher death rate (16.1 deaths per 100 py; 95% CI: 14.7-17.5 deaths per 100 py) than those with a 6MWT of &gt;350 m (7.7 deaths per 100 py; 95% CI: 6.8-8.6 deaths per 100 py). A baseline 6MWT distance of &lt;350 m was associated with a 2.2-fold higher risk of mortality (HR: 2.15; 95% CI: 1.85-2.50; <em>P</em> &lt; 0.001), and the bootstrapped results indicated that the coefficients remained constant across the resamples, suggesting robustness in the association between a 6MWT distance of &lt;350 m and mortality (<a href="#fig2" class="usa-link">Figure 2</a>). The increased risk associated with a 6MWT distance of &lt;350 m was consistent across the spectrum of NAC disease stages (NAC stage 1 disease: HR: 1.90; 95% CI: 1.48-2.46; <em>P</em> &lt; 0.001; NAC stage 2 disease: HR: 1.68; 95% CI: 1.34-2.11; <em>P</em> &lt; 0.001; NAC stage 3 disease: HR: 1.62; 95% CI: 1.11-2.36; <em>P</em> = 0.012; <em>P</em> for interaction = 0.761) and the 3 genotypes (wild type: HR: 1.99; 95% CI: 1.67-2.37; <em>P</em> &lt; 0.001; p.[V142I]: HR: 1.73; 95% CI: 1.20-2.50; <em>P</em> &lt; 0.001; non-p.[V142I]: HR: 3.07; 95% CI: 1.93-4.88; <em>P</em> &lt; 0.001; <em>P</em> for interaction = 0.172). The increased risk remained present regardless of background heart failure therapy and disease-modifying therapies (<a href="#mmc1" class="usa-link">Supplemental Table 3</a>).</p>
<figure class="fig xbox font-sm" id="fig2"><h5 class="obj_head">Figure 2.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11218050_gr2.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0e3/11218050/e076db905ae1/gr2.jpg" loading="lazy" height="555" width="773" alt="Figure 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Baseline 6-Minute Walk Test Distance and Survival</p>
<p>Kaplan-Meier curve demonstrating the association between a 6-minute walk test (6MWT) distance of &lt;350 m and survival.</p></figcaption></figure><p id="p0115">In a multivariable analysis adjusted for covariates age, NAC disease stage, and genotype, a 6MWT distance of &lt;350 m remained independently associated with mortality (HR: 1.54; 95% CI: 1.31-1.81; <em>P</em> &lt; 0.001) (<a href="#mmc1" class="usa-link">Supplemental Table 4</a>). The likelihood ratio test demonstrated that the addition of a 6MWT distance of &lt;350 m to the NAC disease stage significantly improved the goodness of fit of the model (chi-square = 53.30; <em>P</em> &lt; 0.001) and significantly improved the discriminatory ability of the classification compared to the NAC disease stage alone (Akaike information criterion: 10,756 vs 10,781; Harrell C-statistic: 0.66; [95% CI: 0.63-0.68] vs 0.63 [95% CI: 0.60-0.66]; <em>P</em> &lt; 0.001).</p></section><section id="sec2.3.2"><h4 class="pmc_sec_title">Change in 6MWT and disease progression</h4>
<p id="p0120">At 1 year, patients with an absolute reduction in the 6MWT distance of &gt;35 m had a higher mortality rate (20.3 deaths per 100 py; 95% CI: 18.0-23.1 deaths per 100 py) than those with a stable 6MWT distance (11.5 deaths per 100 py; 95% CI: 10.3-13.1 deaths per 100 py), and a reduction of &gt;35 m was associated with a 1.8-fold higher risk of mortality (HR: 1.80; 95% CI: 1.51-2.15; <em>P</em> &lt; 0.001). Patients with a relative reduction in the 6MWT distance of &gt;5% had a higher mortality rate (19.6 deaths per 100 py; 95% CI: 17.6-22.0 deaths per 100 py) than those with a stable 6MWT distance (10.7 deaths per 100 py; 95% CI: 9.4-12.2 deaths per 100 py), and a reduction of &gt;5% was associated with a 1.9-fold higher risk of mortality (HR: 1.89; 95% CI: 1.59-2.24; <em>P</em> &lt; 0.001). The bootstrapped results for both an absolute reduction of &gt;35 m and relative reduction of &gt;5% indicate that the coefficients remained constant across the resamples, suggesting robustness in the association between the change in 6MWT distance and mortality. In the overall population, the model that classified 6MWT worsening as a relative reduction of &gt;5% had a lower Akaike information criterion (6,818 vs 6,825) and marginally higher Harrell C-statistic (0.59 vs 0.57) than the model that classified 6MWT worsening as an absolute reduction of &gt;35 m (<a href="#fig3" class="usa-link">Figure 3</a>).</p>
<figure class="fig xbox font-sm" id="fig3"><h5 class="obj_head">Figure 3.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11218050_gr3.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0e3/11218050/5907d7d39ac4/gr3.jpg" loading="lazy" height="1124" width="788" alt="Figure 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Change in 6-Minute Walk Test Distance and Survival</p>
<p>Landmark Kaplan-Meier curves demonstrating the association between (A) an absolute reduction in the 6-minute walk test distance of &gt;35 m and (B) a relative reduction in 6-minute walk test distance of &gt;5% at the 1-year timepoint and subsequent survival.</p></figcaption></figure><p id="p0125">In 2 separate multivariable analyses adjusted for the covariates age, NAC disease stage, genotype, and 6MWT distance of &lt;350 m, both an absolute reduction of &gt;35 m (HR: 1.87; 95% CI: 1.57-2.23; <em>P</em> &lt; 0.001) and relative reduction of &gt;5% (HR: 1.91; 95% CI: 1.60-2.28; <em>P</em> &lt; 0.001) remained independently associated with mortality (<a href="#mmc1" class="usa-link">Supplemental Table 5</a>). Furthermore, the increased risk of mortality associated with both an absolute reduction of &gt;35 m and a relative reduction of &gt;5% was consistent across the spectrum of NAC disease stages (<em>P</em> for interaction = 0.862 and 0.323, respectively) and the 3 genotypes (<em>P</em> for interaction = 0.730 and 0.945, respectively) (<a href="#undfig2" class="usa-link">Central Illustration</a>). Similarly, the increased risk of mortality was consistent across patients who walked &gt;350 m and &lt;350 m at baseline (<em>P</em> for interaction = 0.978 and 0.722, respectively) (<a href="#mmc1" class="usa-link">Supplemental Table 6</a>).</p>
<figure class="fig xbox font-sm" id="undfig2"><h5 class="obj_head">Central Illustration.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11218050_gr5.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0e3/11218050/5f99c59928bf/gr5.jpg" loading="lazy" height="549" width="765" alt="Central Illustration"></a></p>
<div class="p text-right font-secondary"><a href="figure/undfig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Prognostic Importance of the 6-Minute Walk Test According to Subgroups</p>
<p>The risk of mortality associated with the baseline and change in 6-minute walk test (6MWT) according to subgroups. The first <em>P</em> value for interaction is the interaction between genotypes, and the second is the interaction between disease stages. NAC = National Amyloidosis Centre.</p></figcaption></figure><p id="p0130">In a multivariable model with the covariates age, NAC disease stage, and baseline 6MWT distance of &lt;350 m, NT-proBNP progression (HR: 1.65; 95% CI: 1.38-1.97; <em>P</em> &lt; 0.001), ODI (HR: 1.58; 95% CI: 1.32-1.89; <em>P</em> &lt; 0.001), and absolute reduction in 6MWT of &gt;35 m (HR: 1.70; 95% CI: 1.43-2.03; <em>P</em> &lt; 0.001) remained independently associated with an increased risk of mortality. Compared with patients who did not have any markers of disease progression at 1 year, in whom the death rate was 7.6 deaths per 100 py (95% CI: 6.2-9.3), the death rate was 13.9 deaths per 100 py (95% CI: 12.1-16.1 deaths per 100 py) in patients who had 1 marker of disease progression, 22.4 deaths per 100 py (95% CI: 19.4-26.1 deaths per 100 py) in patients with 2 markers of disease progression, and 32.9 deaths per 100 py (95% CI: 25.8-42.0 deaths per 100 py) in patients with 3 markers of disease progression (<a href="#fig4" class="usa-link">Figure 4</a>).</p>
<figure class="fig xbox font-sm" id="fig4"><h5 class="obj_head">Figure 4.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=11218050_gr4.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0e3/11218050/4be0484ae7f6/gr4.jpg" loading="lazy" height="1182" width="758" alt="Figure 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Markers of Progression and Survival</p>
<p>Landmark Kaplan-Meier curves demonstrating the association between markers of disease progression at the 1-year timepoint and subsequent survival. (A) The 6-minute walk test worsening as an absolute reduction (&gt;35 m). (B) The 6-minute walk test worsening as a relative reduction (&gt;5%).</p></figcaption></figure><p id="p0135">The same variables remained independently associated with an increased risk of mortality after adjustment for a relative reduction in the 6MWT distance of &gt;5% (NT-proBNP progression: HR: 1.67; 95% CI: 1.40-1.99; <em>P</em> &lt; 0.001; ODI: HR: 1.55; 95% CI: 1.30-1.86; <em>P</em> &lt; 0.001; 6MWT reduction of &gt;5%: HR: 1.73; 95% CI: 1.45-2.07; <em>P</em> &lt; 0.001), and similarly, each additional marker of progression was associated with an incremental increased risk of mortality (<a href="#mmc1" class="usa-link">Supplemental Table 7</a>). The increased risk associated with an incremental increase in markers of disease progression at 1 year was similar across the spectrum of NAC disease stages (<em>P</em> for interaction = 0.307) and the 3 genotypes (<em>P</em> for interaction = 0.708).</p></section></section></section><section id="sec3"><h2 class="pmc_sec_title">Discussion</h2>
<p id="p0140">This study is the first, to our knowledge, to comprehensively evaluate the importance of the 6MWT in a large population of patients with ATTR-CA, and it demonstrated the following: 1) 6MWT distance was significantly reduced in patients with ATTR-CA, with the degree of reduction being more severe in older, female patients with the p.(V142I) genotype and those with an advanced disease stage; 2) the 6MWT distance at baseline was independently associated with mortality; 3) absolute (&gt;35 m) and relative (&gt;5%) reductions in the 6MWT distance at 1 year were independently associated with mortality; and 4) combining worsening 6MWT with established measures of disease progression enables further refinement of risk and could be highly relevant both in clinical practice to stratify disease progression and as an endpoint in clinical trials.</p>
<p id="p0145">The 6MWT represents a simple and easily performed yet comprehensive, standardized functional assessment that accurately reflects the severity of cardiac disease and can risk stratify patients beyond the conventional biomarkers (NT-proBNP and eGFR) used in the NAC staging system.<a href="#bib17" class="usa-link" aria-describedby="bib17"><sup>17</sup></a> A baseline distance of &lt;350 m demonstrates remarkable capacity for identifying patients at an increased risk of mortality, with the associated risk being similar across the spectrum of NAC disease stages and the 3 different genotypes. Regardless of the cardiac disease severity or clinical phenotype, the 6MWT can be used alongside conventional markers to refine risk stratification during the baseline assessment and identify high-risk patients who may benefit from a more intensive treatment strategy and more frequent follow-up.</p>
<p id="p0150">The 6MWT is the architype functional test that reflects each individual patient’s capability to conduct activities of daily living, and it is an objective measure that quantifies exercise capacity in a way that is important to patients. Therefore, longitudinal changes in the 6MWT distance have been widely used to demonstrate the efficacy of ATTR-specific disease-modifying therapies. However, the change in 6MWT distance in response to treatment has varied significantly among different agents.<a href="#bib7" class="usa-link" aria-describedby="bib7"><sup>7</sup></a><sup>, </sup><a href="#bib8" class="usa-link" aria-describedby="bib8"><sup>8</sup></a><sup>, </sup><a href="#bib9" class="usa-link" aria-describedby="bib9"><sup>9</sup></a> In the present study, the historical cohort (pre-2017) experienced a more rapid decline than the contemporary cohort (post-2017). This difference is likely to reflect patients in the contemporary cohort being diagnosed earlier in the course of their disease, with a milder cardiac phenotype, and therefore experiencing a slower decline.<a href="#bib1" class="usa-link" aria-describedby="bib1"><sup>1</sup></a> The impact of disease severity at baseline on the trajectory of 6MWT distance decline has been mirrored across different clinical trials. By comparing the trajectories of 6MWT distance decline in placebo patients across clinical trials, patients in more recent trials (ATTRibute-CM) had slower rates of disease progression compared with those in older trials (ATTR-ACT), supporting the hypothesis that the rate of 6MWT distance decline is significantly influenced by the disease stage at baseline.<a href="#bib7" class="usa-link" aria-describedby="bib7"><sup>7</sup></a><sup>,</sup><a href="#bib8" class="usa-link" aria-describedby="bib8"><sup>8</sup></a> In clinical trials, the treatment effect on the rate of 6MWT distance decline will depend on the degree of deterioration in placebo patients, making simple comparisons of treatment effect across different trials based on changes in 6MWT challenging. This further emphasizes the need to define a minimal clinically important difference in the 6MWT at an individual level to ensure that novel therapies are appropriately assessed in the changing landscape of the clinical phenotype of patients with ATTR-CA.</p>
<p id="p0155">In the current study, which represents the largest analysis of functional exercise testing in patients with ATTR-CA to our knowledge, an absolute reduction of &gt;35 m or a relative reduction of &gt;5% at 1 year was independently associated with an increased risk of mortality, even after adjustment for baseline characteristics and other established measures of disease progression. Furthermore, both absolute and relative worsening of the 6MWT distance were consistently associated with a similar increased risk of mortality across the spectrum of NAC disease stages and the 3 different genotypes. Patients with both p.(V142I) and non-p.(V142I) hATTR-CA experienced a more rapid decline in 6MWT distance than those with wtATTR-CA, and the presence of a hereditary genotype remained independently associated with the decline in 6MWT distance after adjustment for baseline characteristics and established markers of disease progression. It is possible that these differences are explained by intrinsic differences in disease biology between the different genotypes. The p.(V142I) genotype is associated with a more aggressive and rapidly progressive cardiomyopathy, whereas the non-p.(V142I) genotype is most commonly associated with a mixed phenotype, comprising a cardiomyopathy and peripheral polyneuropathy.<a href="#bib18" class="usa-link" aria-describedby="bib18"><sup>18</sup></a> The progression of cardiac disease invariably negatively influences exercise performance, and neuropathic involvement impairs balance, mobility, coordination, and postural stability, the combination of which are all assessed during the 6MWT. This illustrates the utility of the 6MWT as a comprehensive measure of functional capacity and its importance in monitoring the complex and multifaceted ATTR-CA disease process. The novel definitions of 6MWT worsening identified in this study could easily be applied in clinical practice to guide optimization of treatment strategies and as an endpoint in clinical trials. The use of 6MWT worsening as a surrogate marker of disease progression in clinical trials would enable the measurement of a metric that is clinically meaningful to both patients and clinicians alike while also potentially reducing the number of patients and length of follow-up required to evaluate the efficacy of novel agents.</p>
<p id="p0160">Despite the 6MWT representing an important tool in the assessment of ATTR-specific disease-modifying therapies, many heart failure therapies shown to improve outcomes in the general heart failure population have failed to improve the 6MWT distance. This discrepancy is likely multifactorial in nature. Trials of heart failure therapies tend to reassess the 6MWT distance between 4 and 6 months,<a href="#bib19" class="usa-link" aria-describedby="bib19"><sup>19</sup></a><sup>,</sup><a href="#bib20" class="usa-link" aria-describedby="bib20"><sup>20</sup></a> whereas in trials of ATTR-specific therapies, reassessment took place between 12 and 30 months.<a href="#bib7" class="usa-link" aria-describedby="bib7"><sup>7</sup></a><sup>, </sup><a href="#bib8" class="usa-link" aria-describedby="bib8"><sup>8</sup></a><sup>, </sup><a href="#bib9" class="usa-link" aria-describedby="bib9"><sup>9</sup></a> The magnitude of change in 6MWT distance is likely to be amplified as the follow-up duration extends, and therefore longer follow-up may be required to detect meaningful differences. This observation may also reflect inherent differences in disease biology, with ATTR-CA representing a well-defined, severe form of heart failure with a known pathophysiology for which highly-specific treatments are available.<a href="#bib21" class="usa-link" aria-describedby="bib21"><sup>21</sup></a> The severity of ATTR-CA is evident in accelerated 6MWT distance decline, and treatments targeting ATTR-specific disease pathways have consistently demonstrated clinically meaningful and significant changes in the 6MWT distance across all 3 large, randomized, placebo-controlled trials of disease-modifying therapy.<a href="#bib7" class="usa-link" aria-describedby="bib7"><sup>7</sup></a><sup>, </sup><a href="#bib8" class="usa-link" aria-describedby="bib8"><sup>8</sup></a><sup>, </sup><a href="#bib9" class="usa-link" aria-describedby="bib9"><sup>9</sup></a> This observation emphasizes important distinctions between different heart failure etiologies and underscores the necessity for tailored functional tests to evaluate the efficacy of disease-specific therapies.</p>
<p id="p0165">Although the decline in 6MWT distance was associated with both NT-proBNP progression and ODI, all 3 markers of disease progression remained independently associated with mortality, indicating that each marker is capturing a slightly different aspect of the underlying disease process. NT-proBNP elevation reflects a combination of pathophysiologic biochemical processes occurring in response to cardiac amyloid infiltration, such as neurohormonal activation, impaired renal filtration, and fluid status.<a href="#bib17" class="usa-link" aria-describedby="bib17"><sup>17</sup></a> ODI acts as a surrogate marker of worsening heart failure symptoms secondary to fluid accumulation,<a href="#bib13" class="usa-link" aria-describedby="bib13"><sup>13</sup></a> and the 6MWT is a comprehensive functional assessment that provides a measure of cardiovascular robustness while also accounting for the extent of neuropathic involvement.<a href="#bib5" class="usa-link" aria-describedby="bib5"><sup>5</sup></a><sup>,</sup><a href="#bib6" class="usa-link" aria-describedby="bib6"><sup>6</sup></a> The combination of these variables provides incremental information to each individual variable and allows further refinement of the rate of disease progression and risk of mortality.</p>
<p id="p0170">Considering the likely availability of various novel therapeutic agents in the near future, the ability to reliably detect patients experiencing disease progression is of paramount importance.<a href="#bib10" class="usa-link" aria-describedby="bib10"><sup>10</sup></a> The presence of all 3 markers of disease progression was associated with a &gt;4-fold higher risk of mortality and could signify the need to either switch to alternative agents with different mechanisms of actions or consider intensifying treatment with combination therapy. These markers are widely available, simple to measure, and inexpensive. Their universal applicability across the spectrum of NAC disease stages and different genotypes should support their widespread adoption to identify patients experiencing disease progression.</p>
<section id="sec3.1"><h3 class="pmc_sec_title">Study limitations</h3>
<p id="p0175">There is a possible selection bias, in that only patients who were able to complete a baseline 6MWT assessment were eligible for inclusion. There is also an invariable survival bias in the assessment of 6MWT worsening, and therefore it may be that the extent of differences is underestimated, and rapid disease progression may have resulted in death before the follow-up assessment.</p></section></section><section id="sec4"><h2 class="pmc_sec_title">Conclusions</h2>
<p id="p0180">In this large cohort of patients with ATTR-CA, the baseline 6MWT distance refined risk stratification and reliably identified patients at a higher risk of mortality regardless of their disease stage or genotype. Worsening of the 6MWT at 1 year was common and independently associated with an increased risk of mortality, even after adjustment for established markers of disease progression. The combination of 3 markers of progression (NT-proBNP progression, ODI, and 6MWT worsening) enabled further refinement of risk and facilitated the detection of patients experiencing rapid disease progression who are at the highest risk of mortality.</p>
<section class="bt xbox font-sm" id="dtbox1"><h3 class="obj_head">Perspectives.</h3>
<p id="p0185"><strong>COMPETENCY IN PATIENT CARE AND PROCEDURAL SKILLS:</strong> The 6MWT distance at baseline is associated with an increased mortality in patients with ATTR-CA, across genotypes and disease stages.</p>
<p id="p0190"><strong>TRANSLATIONAL OUTLOOK:</strong> Further research is needed to assess the incremental value of the 6MWT beyond other biomarkers to improve risk stratification and guide treatment in patients with ATTR-CA.</p></section></section><section id="sec17"><h2 class="pmc_sec_title">Funding Support and Author Disclosures</h2>
<p id="p0195">Dr Wechalekar has received consulting income from Alexia, AstraZeneca, Janssen, Attralus, and Prothena. Dr Solomon has received research grants from Alexion, Alnylam, AstraZeneca, Bellerophon, Bayer, BMS, Cytokinetics, Eidos, Gossamer, GSK, Ionis, Lilly, MyoKardia, National Institutes of Health/National Heart, Lung, and Blood Institute, Novartis, Novo Nordisk, Respicardia, Sanofi Pasteur, Theracos, and US2.AI; and has consulted for Abbott, Action, Akros, Alexion, Alnylam, Amgen, Arena, AstraZeneca, Bayer, Boehringer Ingelheim, BMS, Cardior, Cardurion, Corvia, Cytokinetics, Daiichi-Sankyo, GSK, Lilly, Merck, Myokardia, Novartis, Roche, Theracos, Quantum Genomics, Cardurion, Janssen, Cardiac Dimensions, Tenaya, Sanofi Pasteur, Dinaqor, Tremeau, CellProThera, Moderna, American Regent, Sarepta, Lexicon, Anacardio, Akros, and Valo. Dr Gilmore has received consulting income from Ionis, Eidos, Intellia, Alnylam, and Pfizer. Dr Fontana is supported by a British Heart Foundation Intermediate Clinical Research Fellowship (FS/18/21/33447); and has received consulting income from Intellia, Novo Nordisk, Pfizer, Eidos, Prothena, Akcea, Alnylam, Caleum, Alexion, Janssen, Ionis, and AstraZeneca. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.</p></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="d36e2908"><p id="ntpara1011"><a href="http://www.onlinejacc.org/podcasts" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer"><strong>Listen to this manuscript's audio summary by Editor Emeritus Dr Valentin Fuster on</strong></a><a href="https://www.jacc.org/journal/jacc" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer"><strong>www.jacc.org/journal/jacc</strong></a>.</p></div>
<div class="fn p" id="d36e2915"><p id="ntpara0010">James L. Januzzi, MD, served as Guest Associate Editor for this paper.</p></div>
<div class="fn p" id="d36e2918"><p id="ntpara0015aa">The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the <a href="https://www.jacc.org/author-center" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Author Center</a>.</p></div>
<div class="fn p" id="appsec2">
<p>Appendix</p>
<p id="p0205">For supplemental tables and an expanded Results section, please see the online version of this paper.</p>
</div>
</div></section><section id="appsec1"><h2 class="pmc_sec_title">Appendix</h2>
<section class="sm xbox font-sm" id="mmc1"><div class="caption p"><span>Supplemental Material</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/11218050/bin/mmc1.docx" data-ga-action="click_feat_suppl" class="usa-link">mmc1.docx</a><sup> (50.5KB, docx) </sup>
</div></div></section></section><section id="cebib0010" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="cebib0010_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="bib1">
<span class="label">1.</span><cite>Ioannou A., Patel R.K., Razvi Y., et al.  Impact of earlier diagnosis in cardiac ATTR amyloidosis over the course of 20 years. Circulation. 2022;146:1657–1670. doi: 10.1161/CIRCULATIONAHA.122.060852.</cite> [<a href="https://doi.org/10.1161/CIRCULATIONAHA.122.060852" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9698091/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36325894/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Impact%20of%20earlier%20diagnosis%20in%20cardiac%20ATTR%20amyloidosis%20over%20the%20course%20of%2020%20years&amp;author=A.%20Ioannou&amp;author=R.K.%20Patel&amp;author=Y.%20Razvi&amp;volume=146&amp;publication_year=2022&amp;pages=1657-1670&amp;pmid=36325894&amp;doi=10.1161/CIRCULATIONAHA.122.060852&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib2">
<span class="label">2.</span><cite>Ioannou A., Patel R.K., Razvi Y., et al.  Multi-imaging characterization of cardiac phenotype in different types of amyloidosis. J Am Coll Cardiol Img. 2022;16:464–477. doi: 10.1016/j.jcmg.2022.07.008.</cite> [<a href="https://doi.org/10.1016/j.jcmg.2022.07.008" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36648052/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%C2%A0Am%20Coll%20Cardiol%20Img&amp;title=Multi-imaging%20characterization%20of%20cardiac%20phenotype%20in%20different%20types%20of%20amyloidosis&amp;author=A.%20Ioannou&amp;author=R.K.%20Patel&amp;author=Y.%20Razvi&amp;volume=16&amp;publication_year=2022&amp;pages=464-477&amp;pmid=36648052&amp;doi=10.1016/j.jcmg.2022.07.008&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib3">
<span class="label">3.</span><cite>Porcari A., Razvi Y., Masi A., et al.  Prevalence, characteristics and outcomes of older patients with hereditary versus wild-type transthyretin amyloid cardiomyopathy. Eur J Heart Fail. 2023;25:515–524. doi: 10.1002/ejhf.2776.</cite> [<a href="https://doi.org/10.1002/ejhf.2776" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36644836/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20J%20Heart%20Fail&amp;title=Prevalence,%20characteristics%20and%20outcomes%20of%20older%20patients%20with%20hereditary%20versus%20wild-type%20transthyretin%20amyloid%20cardiomyopathy&amp;author=A.%20Porcari&amp;author=Y.%20Razvi&amp;author=A.%20Masi&amp;volume=25&amp;publication_year=2023&amp;pages=515-524&amp;pmid=36644836&amp;doi=10.1002/ejhf.2776&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib4">
<span class="label">4.</span><cite>Patel R.K., Ioannou A., Razvi Y., et al.  Sex differences among patients with transthyretin amyloid cardiomyopathy—from diagnosis to prognosis. Eur J Heart Fail. 2022;24:2355–2363. doi: 10.1002/ejhf.2646.</cite> [<a href="https://doi.org/10.1002/ejhf.2646" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10087683/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36575133/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20J%20Heart%20Fail&amp;title=Sex%20differences%20among%20patients%20with%20transthyretin%20amyloid%20cardiomyopathy%E2%80%94from%20diagnosis%20to%20prognosis&amp;author=R.K.%20Patel&amp;author=A.%20Ioannou&amp;author=Y.%20Razvi&amp;volume=24&amp;publication_year=2022&amp;pages=2355-2363&amp;pmid=36575133&amp;doi=10.1002/ejhf.2646&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib5">
<span class="label">5.</span><cite>Bittner V., Weiner D.H., Yusuf S., et al.  Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. JAMA. 1993;270:1702–1707.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/8411500/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=Prediction%20of%20mortality%20and%20morbidity%20with%20a%206-minute%20walk%20test%20in%20patients%20with%20left%20ventricular%20dysfunction&amp;author=V.%20Bittner&amp;author=D.H.%20Weiner&amp;author=S.%20Yusuf&amp;volume=270&amp;publication_year=1993&amp;pages=1702-1707&amp;pmid=8411500&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib6">
<span class="label">6.</span><cite>Opasich C., Pinna G.D., Mazza A., et al.  Six-minute walking performance in patients with moderate-to-severe heart failure; is it a useful indicator in clinical practice? Eur Heart J. 2001;22:488–496. doi: 10.1053/euhj.2000.2310.</cite> [<a href="https://doi.org/10.1053/euhj.2000.2310" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11237544/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20Heart%20J&amp;title=Six-minute%20walking%20performance%20in%20patients%20with%20moderate-to-severe%20heart%20failure;%20is%20it%20a%20useful%20indicator%20in%20clinical%20practice?&amp;author=C.%20Opasich&amp;author=G.D.%20Pinna&amp;author=A.%20Mazza&amp;volume=22&amp;publication_year=2001&amp;pages=488-496&amp;pmid=11237544&amp;doi=10.1053/euhj.2000.2310&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib7">
<span class="label">7.</span><cite>Maurer M.S., Schwartz J.H., Gundapaneni B., et al.  Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N Engl J Med. 2018;379:1007–1016. doi: 10.1056/NEJMoa1805689.</cite> [<a href="https://doi.org/10.1056/NEJMoa1805689" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30145929/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%C2%A0Engl%20J%20Med&amp;title=Tafamidis%20treatment%20for%20patients%20with%20transthyretin%20amyloid%20cardiomyopathy&amp;author=M.S.%20Maurer&amp;author=J.H.%20Schwartz&amp;author=B.%20Gundapaneni&amp;volume=379&amp;publication_year=2018&amp;pages=1007-1016&amp;pmid=30145929&amp;doi=10.1056/NEJMoa1805689&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib8">
<span class="label">8.</span><cite>Gillmore J.D., Judge D.P., Cappelli F., et al.  Efficacy and safety of acoramidis in transthyretin amyloid cardiomyopathy. N Engl J Med. 2024;390:132–142. doi: 10.1056/NEJMoa2305434.</cite> [<a href="https://doi.org/10.1056/NEJMoa2305434" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38197816/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%C2%A0Engl%20J%20Med&amp;title=Efficacy%20and%20safety%20of%20acoramidis%20in%20transthyretin%20amyloid%20cardiomyopathy&amp;author=J.D.%20Gillmore&amp;author=D.P.%20Judge&amp;author=F.%20Cappelli&amp;volume=390&amp;publication_year=2024&amp;pages=132-142&amp;pmid=38197816&amp;doi=10.1056/NEJMoa2305434&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib9">
<span class="label">9.</span><cite>Maurer M.S., Kale P., Fontana M., et al.  Patisiran treatment in patients with transthyretin cardiac amyloidosis. N Engl J Med. 2023;389:1553–1565. doi: 10.1056/NEJMoa2300757.</cite> [<a href="https://doi.org/10.1056/NEJMoa2300757" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10757426/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37888916/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%C2%A0Engl%20J%20Med&amp;title=Patisiran%20treatment%20in%20patients%20with%20transthyretin%20cardiac%20amyloidosis&amp;author=M.S.%20Maurer&amp;author=P.%20Kale&amp;author=M.%20Fontana&amp;volume=389&amp;publication_year=2023&amp;pages=1553-1565&amp;pmid=37888916&amp;doi=10.1056/NEJMoa2300757&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib10">
<span class="label">10.</span><cite>Ioannou A., Fontana M., Gillmore J.D. RNA targeting and gene editing strategies for transthyretin amyloidosis. BioDrugs. 2023;37:127–142. doi: 10.1007/s40259-023-00577-7.</cite> [<a href="https://doi.org/10.1007/s40259-023-00577-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9933836/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36795354/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BioDrugs&amp;title=RNA%20targeting%20and%20gene%20editing%20strategies%20for%20transthyretin%20amyloidosis&amp;author=A.%20Ioannou&amp;author=M.%20Fontana&amp;author=J.D.%20Gillmore&amp;volume=37&amp;publication_year=2023&amp;pages=127-142&amp;pmid=36795354&amp;doi=10.1007/s40259-023-00577-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib11">
<span class="label">11.</span><cite>Garcia-Pavia P., Bengel F., Brito D., et al.  Expert consensus on the monitoring of transthyretin amyloid cardiomyopathy. Eur J Heart Fail. 2021;23:895–905. doi: 10.1002/ejhf.2198.</cite> [<a href="https://doi.org/10.1002/ejhf.2198" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8239846/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33915002/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20J%20Heart%20Fail&amp;title=Expert%20consensus%20on%20the%20monitoring%20of%20transthyretin%20amyloid%20cardiomyopathy&amp;author=P.%20Garcia-Pavia&amp;author=F.%20Bengel&amp;author=D.%20Brito&amp;volume=23&amp;publication_year=2021&amp;pages=895-905&amp;pmid=33915002&amp;doi=10.1002/ejhf.2198&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib12">
<span class="label">12.</span><cite>Crapo R.O., Casaburi R., Coates A.L., et al.  ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166:111–117. doi: 10.1164/ajrccm.166.1.at1102.</cite> [<a href="https://doi.org/10.1164/ajrccm.166.1.at1102" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12091180/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Respir%20Crit%20Care%20Med&amp;title=ATS%20statement:%20guidelines%20for%20the%20six-minute%20walk%20test&amp;author=R.O.%20Crapo&amp;author=R.%20Casaburi&amp;author=A.L.%20Coates&amp;volume=166&amp;publication_year=2002&amp;pages=111-117&amp;pmid=12091180&amp;doi=10.1164/ajrccm.166.1.at1102&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib13">
<span class="label">13.</span><cite>Ioannou A., Cappelli F., Emdin M., et al.  Stratifying disease progression in patients with cardiac ATTR amyloidosis. J Am Coll Cardiol. 2024;83(14):1276–1291. doi: 10.1016/j.jacc.2023.12.036.</cite> [<a href="https://doi.org/10.1016/j.jacc.2023.12.036" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11004588/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38530684/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%C2%A0Am%20Coll%20Cardiol&amp;title=Stratifying%20disease%20progression%20in%20patients%20with%20cardiac%20ATTR%20amyloidosis&amp;author=A.%20Ioannou&amp;author=F.%20Cappelli&amp;author=M.%20Emdin&amp;volume=83&amp;issue=14&amp;publication_year=2024&amp;pages=1276-1291&amp;pmid=38530684&amp;doi=10.1016/j.jacc.2023.12.036&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib14">
<span class="label">14.</span><cite>Khan M.S., Anker S.D., Friede T., et al.  Minimal clinically important differences in 6-minute walk test in patients with HFrEF and iron deficiency. J Card Fail. 2023;29:760–770. doi: 10.1016/j.cardfail.2022.10.423.</cite> [<a href="https://doi.org/10.1016/j.cardfail.2022.10.423" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36332897/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%C2%A0Card%20Fail&amp;title=Minimal%20clinically%20important%20differences%20in%206-minute%20walk%20test%20in%20patients%20with%20HFrEF%20and%20iron%20deficiency&amp;author=M.S.%20Khan&amp;author=S.D.%20Anker&amp;author=T.%20Friede&amp;volume=29&amp;publication_year=2023&amp;pages=760-770&amp;pmid=36332897&amp;doi=10.1016/j.cardfail.2022.10.423&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib15">
<span class="label">15.</span><cite>Mathai S.C., Puhan M.A., Lam D., Wise R.A. The minimal important difference in the 6-minute walk test for patients with pulmonary arterial hypertension. Am J Respir Crit Care Med. 2012;186:428–433. doi: 10.1164/rccm.201203-0480OC.</cite> [<a href="https://doi.org/10.1164/rccm.201203-0480OC" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3443803/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22723290/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am%20J%20Respir%20Crit%20Care%20Med&amp;title=The%20minimal%20important%20difference%20in%20the%206-minute%20walk%20test%20for%20patients%20with%20pulmonary%20arterial%20hypertension&amp;author=S.C.%20Mathai&amp;author=M.A.%20Puhan&amp;author=D.%20Lam&amp;author=R.A.%20Wise&amp;volume=186&amp;publication_year=2012&amp;pages=428-433&amp;pmid=22723290&amp;doi=10.1164/rccm.201203-0480OC&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib16">
<span class="label">16.</span><cite>Bohannon R.W., Crouch R. Minimal clinically important difference for change in 6-minute walk test distance of adults with pathology: a systematic review. J Eval Clin Pract. 2017;23:377–381. doi: 10.1111/jep.12629.</cite> [<a href="https://doi.org/10.1111/jep.12629" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27592691/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%C2%A0Eval%20Clin%20Pract&amp;title=Minimal%20clinically%20important%20difference%20for%20change%20in%206-minute%20walk%20test%20distance%20of%20adults%20with%20pathology:%20a%20systematic%20review&amp;author=R.W.%20Bohannon&amp;author=R.%20Crouch&amp;volume=23&amp;publication_year=2017&amp;pages=377-381&amp;pmid=27592691&amp;doi=10.1111/jep.12629&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib17">
<span class="label">17.</span><cite>Gillmore J.D., Damy T., Fontana M., et al.  A new staging system for cardiac transthyretin amyloidosis. Eur Heart J. 2018;39:2799–2806. doi: 10.1093/eurheartj/ehx589.</cite> [<a href="https://doi.org/10.1093/eurheartj/ehx589" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29048471/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20Heart%20J&amp;title=A%C2%A0new%20staging%20system%20for%20cardiac%20transthyretin%20amyloidosis&amp;author=J.D.%20Gillmore&amp;author=T.%20Damy&amp;author=M.%20Fontana&amp;volume=39&amp;publication_year=2018&amp;pages=2799-2806&amp;pmid=29048471&amp;doi=10.1093/eurheartj/ehx589&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib18">
<span class="label">18.</span><cite>Razvi Y., Ioannou A., Patel R.K., et al.  Deep phenotyping of p.(V142I)-associated variant ATTR amyloid cardiomyopathy: distinct from wild-type ATTR amyloidosis? Eur J Heart Fail. 2023;26(2):383–393. doi: 10.1002/ejhf.3088.</cite> [<a href="https://doi.org/10.1002/ejhf.3088" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37953725/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20J%20Heart%20Fail&amp;title=Deep%20phenotyping%20of%20p.(V142I)-associated%20variant%20ATTR%20amyloid%20cardiomyopathy:%20distinct%20from%20wild-type%20ATTR%20amyloidosis?&amp;author=Y.%20Razvi&amp;author=A.%20Ioannou&amp;author=R.K.%20Patel&amp;volume=26&amp;issue=2&amp;publication_year=2023&amp;pages=383-393&amp;pmid=37953725&amp;doi=10.1002/ejhf.3088&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib19">
<span class="label">19.</span><cite>Mcmurray J.J.V., Docherty K.F., de Boer R.A., et al.  Effect of dapagliflozin versus placebo on symptoms and 6-minute walk distance in patients with heart failure: the DETERMINE randomized clinical trials. Circulation. 2023;149(11):825–838. doi: 10.1161/CIRCULATIONAHA.123.065061.</cite> [<a href="https://doi.org/10.1161/CIRCULATIONAHA.123.065061" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38059368/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Circulation&amp;title=Effect%20of%20dapagliflozin%20versus%20placebo%20on%20symptoms%20and%206-minute%20walk%20distance%20in%20patients%20with%20heart%20failure:%20the%20DETERMINE%20randomized%20clinical%20trials&amp;author=J.J.V.%20Mcmurray&amp;author=K.F.%20Docherty&amp;author=R.A.%20de%20Boer&amp;volume=149&amp;issue=11&amp;publication_year=2023&amp;pages=825-838&amp;pmid=38059368&amp;doi=10.1161/CIRCULATIONAHA.123.065061&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib20">
<span class="label">20.</span><cite>Pieske B., Wachter R., Shah S.J., et al.  Effect of sacubitril/valsartan vs standard medical therapies on plasma NT-proBNP concentration and submaximal exercise capacity in patients with heart failure and preserved ejection fraction: the PARALLAX randomized clinical trial. JAMA. 2021;326:1919–1929. doi: 10.1001/jama.2021.18463.</cite> [<a href="https://doi.org/10.1001/jama.2021.18463" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8596197/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34783839/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=Effect%20of%20sacubitril/valsartan%20vs%20standard%20medical%20therapies%20on%20plasma%20NT-proBNP%20concentration%20and%20submaximal%20exercise%20capacity%20in%20patients%20with%20heart%20failure%20and%20preserved%20ejection%20fraction:%20the%20PARALLAX%20randomized%20clinical%20trial&amp;author=B.%20Pieske&amp;author=R.%20Wachter&amp;author=S.J.%20Shah&amp;volume=326&amp;publication_year=2021&amp;pages=1919-1929&amp;pmid=34783839&amp;doi=10.1001/jama.2021.18463&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib21">
<span class="label">21.</span><cite>Ioannou A., Massa P., Patel R.K., et al.  Conventional heart failure therapy in cardiac ATTR amyloidosis. Eur Heart J. 2023;44:2893–2907. doi: 10.1093/eurheartj/ehad347.</cite> [<a href="https://doi.org/10.1093/eurheartj/ehad347" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10424879/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37216684/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Eur%20Heart%20J&amp;title=Conventional%20heart%20failure%20therapy%20in%20cardiac%20ATTR%C2%A0amyloidosis&amp;author=A.%20Ioannou&amp;author=P.%20Massa&amp;author=R.K.%20Patel&amp;volume=44&amp;publication_year=2023&amp;pages=2893-2907&amp;pmid=37216684&amp;doi=10.1093/eurheartj/ehad347&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p"><span>Supplemental Material</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/11218050/bin/mmc1.docx" data-ga-action="click_feat_suppl" class="usa-link">mmc1.docx</a><sup> (50.5KB, docx) </sup>
</div></div></section></section></section></section></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1016/j.jacc.2024.04.011"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/main.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (1.0 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/11218050/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/11218050/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC11218050%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC11218050/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC11218050/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC11218050/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/38739065/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC11218050/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/38739065/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC11218050/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/11218050/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="fPhmtwaoaaTXR6uuGb2uapzZTt7LB7Vfgy43WhyA7w8tbzNPUp7aY31zEhnleHCT">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
